TitleGenColors Logo

Gene list

Applied filters:

COG category: Cell wall/membrane biogenesis
Organism: Staphylococcus haemolyticus JCSC1435, JCSC1435
Gene type: CDS

Number of genes found: 123

Free access
Sort by:

 



# Staphylococcus haemolyticus JCSC1435, JCSC1435

>SH1736 
MFHHISVMLNETIDYLDIKEDGIYVDCTLGGAGHALYLLNQLNDDGRLIA
IDQDTTALDNAKEVLKDHLHKVTFVHSNFRELTDILKNLNIEKVDGIYYD
LGVSSPQLDVPERGFSYHHDAKLDMRMDQTQQLSAYEVVNQWPYEALVKI
FYRYGEEKFSKQIARRIETHREHQPIETTLELVDIIKEGIPAKARRKGGH
PAKRVFQAIRIAVNDELSAFEDSIEQAIELVKVGGRISVITFHSLEDRLC
KQMFQEYEKGPDVPRGLPIIPEAYTPKLKRVNRKPITATDTDLDENNRAR
SAKLRVAEILK
>SH1598 
MIHSGKIRIDINPEKQNRHCKNHRLFEESKSKAIKNNYMLPSYTTIPNRE
LNKLLMEKSNTGIMLLVNNKFNKKEIIDFGVVIGKAFVNGRYINTKLGKV
HYSKTGTHVVPYIKKEMKK
>SH1089 
MGSSIVLKMLNVTHYYRSKKNRKWYLPFGYAAEDIELNNISLHIYQGEAL
AIIGEPGASKTLLGRIIAGDIKPDRGKINKSVSTYYGDIKDKHLIHLTVR
QYVKEIQRLFSYETTSHSVDQIIKFAHLDDKSTFNINMLSHSDFAQLILS
IARVCRKELIILNHIIEHLDEDFLEKAKQLSKDYVNDNNSLVFIDNDLEK
VEKVSNYVAWISHGQVRMEGSLNQVLPVFKEHEQDRMSIGNDEEQQNFDL
DWKESRSRLPEMSYNFKRVERYRHAKVPDFVVRFWTILIASLICLAIVGA
LVVNNIGRFDVPIIEAQKKVENKDPFEEKLAYGIVLDDSITLNGDSNTKV
PKYAFLTITGENSKKYRVNIDNQDYVVEKHKLQYFNPAALYESHSFKKLS
PYMKSNYSNFVDYYNSHLHKKHDRVKKTLVPNKDSRYVVGVTQQPVEMLF
NDQDKLTGFVFPIINKDELKDKYHINQDLWIVKSGDGYLIADMKNSKWIY
IEL
>SH0476 
MKEQYGVYSVQPIIVDDIEEELRQGKMIIKTAEEQNIDYVVYSTAGGVNR
DRTGPHFEALADIENELKDSSLNYTIIKPSFFMDNFLRITKVENGEIMIP
EFINQDVKFAMISSIDIARIASNVFGNPEKYNHQAIEIASDELTLKEVVK
TFAMVTGKPTEIKGSFSSGTAERGWLEEKGYIIDFNQMDEINPGRLTLEQ
WISEVNF
>SH0542 
MIREAKIEDLPAILSIYNDAILHTTAVYTYDIQTLDERKAWFDMKNKANE
PIFVFEQAGKAVGFATYGQFRNWPAYLYSIEHSIYVDKSNRGKGIASQLL
QHLIEDARTRNYRTIVAGIDASNDSSIKLHEKFNFKHAGTIQNVGYKFDR
WLDLAFYQYDLHDK
>SH0385 
MKRIFDIGISSMILFFSLPVLVIIFILSFIFLGKPVFFKQERAGLNGEPF
NIIKFRTMKDKRDSEGKLLPNKDRANWFGDILRSTSIDELPQLFNVLKGD
LSLVGPRPLHIEYNQYYNDRQKKRLDVRPGITGLAQINGRNTISWTNKFQ
YDTWYVENMSTILDAYIIYKTFSKVLKRQDINSKDNTQVERFNGNN
>SH1731 
MKDKRRKDNKVSSIQSLIEKRNRELNNEEHLSNHDANHKDKNKISTDDAQ
LYKINKPNETSKQQDQNQSIDEDNFNNQSNESEQLEQNEAIEQSNETSDE
NAQNVESTKTNDSHRLSTNSSENTYKLSIKDRVKEFNDNRKRKKHAKSTQ
FDHLSPQERKEQLRIQRRKRQKRIQYVIITFLVLLIILFLLYMFTPLSRI
SNIKISGNNNVSNSQVEKALDVKDNSRMYTYSKRKGIQNLKKNDLIKDVK
IKKQLPNTLKVQITENQVVGVVKEKNKYVPIIEGNQELKNFDGNIAGSGP
ILEGFKGEEKSNMIKSLSKMSPEIRDMISEIKYAPKQNSPNRILLYMQDD
MQVVGNIKTIANKIKYYPQMSQSLSKDDSGNLKTQGYIDLSVGASFIPYN
ENSSGDSKSDQNVRQKSQQETDAKDELQSALNKINEQSDSNN
>SH0483 
MKQFIKIVMTILICVGIGVSVTYLIREIDIQPSQMTLNDDNQFGDWKRDG
RLTHGYGTYNHGLEFEGNDKHYGNDYDLPENTEVLAATDGVVTRLFEDEL
GGKVIQISESNGQYHQWYMHLNDFKVTQGQKVKAGDVIALSGNTGEQTTG
SHLHFQRMKGGIGNDYAEDPQPFINQLPEKEKSLFNI
>SH2430 fibrinogen-binding protein SdrG
MNKLAAASQGQNVNDLITVSNQYIEEGQNNDGIIRAHEDEPITYHSDITV
DDAVNSGDTMTIDYDSHTIPSDLTDQYFVPDIADSNGDIIATGTYDDATK
RATYTFTVFVDTHSNVTGTLSLSSFIDKSKVPARDTNIDMTFKTANTAYN
QNFTVDYQYPEVEGDSNI
>SH1061 
MRQWTATHLAKLARKASIAAGKKGTDLPGQVARKVDQNILRKLAAQVDDI
VFISGTNGKTTTSNLIGHTLKANHIDIIHNNEGANMAAGITSAFIMQSTK
NTKVAIIEIDEGSIPRVLKEVTPSMMIFTNFFRDQMDRFGEIDIMVNNIA
KSISNKGIKLLLNADDPFVSRLKIASDSIVYYGMKAHAHEFEQSTMNESK
YCPNCGKLLVYDYIHYNQIGHYHCSCGFKRELPKYEVSSFTVSPFLALNI
NETTFNMKIAGDFNAYNALAAYTVLRELGLNDESIRIGFESYTSDNGRMQ
YFKLDYKEAMINLAKNPAGMNASLSVGEQLVGKKVYVISLNDNAADGRDT
SWIYDADFEKLSEQNIETIIVTGTRAEELQLRLKLAEVNVPIILEKDIYK
ATAMTMNYEGFTVAIPNYTSLSPMLEQLNRSFKGGQ
>SH2190 
MKIRVIVPCFNEGEVVTKTYDKLTEILMEDSLDKGYDYDLLFVDDGSKDN
TIDHVQHLASLDQHVKYISFSRNFGKESAMIAGFQHSVKCDAVVMVDGDL
QHPPEFIPQMIEGFQEGYDQVIAKRDRTGENIARKSMTKLYYKLINSFVE
DIEFIDGVGDFRLLSQRAVKAMSSLKEYNRFSKGLFEWIGYNTKIFTYQN
VEREAGHSKWTFTKLLNYGIDGLISFNNKPLRAMIYLGMTIFSLSIVYIL
YLLIGIMVNGINNPGYFTTIAAVLLIGGIQLISIGVVGEYIGRIYYEVKQ
RPKYIVQASNLKEPTHDLKVVEQEKEKVH
>SH1090 
MIDNILLYIKLFPSLIKFTKQRIIDTWKRFAILFIAELVLVLIALITLSF
IEIEDISKARWLYRIVAMITFATMFATIFKSFKEYSQDYLITKSFQSTPL
ITTVANALIGSSICCILSIITLLFKPVNFDASFTAFIVFYIMMILFIIFI
SVTLGLLDIIYKNMTMIFWLAVVINFFIVPIIFIPSANENLMIQLLKLNP
LFYLIDGLATSTIYGVVNMYNISYHIYFILIIVTIGAINFMLMRYVDKVR
IIV
>SH0186 
MKKFLTILILSTLILCACNFEQDVENKHDRNASTKTTGNEQKKKEVINGR
TYYDGILIVNKTTKLPSDYNPGEKPKAQRALQRMFTDAEKDGVSLYKISG
FRSYETQVNLYNQYVARDGEQAADRYSARPGTSEHQSGLSYDVGAIGSAC
NLREQFGETKEGQWIARNAHRYGFIIRYPKGKEQITGYQYEPWHLRYLGK
NNAAKVQHSGQALEEYVRYKDRSES
>SH2424 
MLTIKKIFNIIGGELKDAHNKEANEINDFETIYKFVNSKKTAYFSPNKET
WSRELGRNKNALDGNDLVNKENGEIGLIITENYISDLKFEIPQIIVEDSV
QAFKQLAIYIRNQYTNPVIAITGSMGKSSTRMLITSLLGDYNVLENRGNN
NVRAAIYNNMLKLIKNPDFAVIETSMNAINYLENTSTFLKPDIAIITGIG
EAHFSTFKSVKDIAKIKTRIFDGLSSTTGVAIINKDTLYADYLIDKAHEN
ASNVLTYSINKDAKADLTVDNIKYNKGSIELSITNQENKSEIYRLNTISE
GMVSNTLASILTLKSLNLPIKQELLNDFKPFSKILALKEIHAKTHKLTLL
DDTHNASLPAMINAIRAFNSQTKFYSGHKIIAIGKISDLGRKSNETHLKL
VEELENSNADYILCKDNELRQVVNKVRNKNITWYPNKELLINDLKYLCNE
DSLTLLKSSVTGTDFPEIAKNLPNILRDNNIEFDFDDLFKKLSEVGKSYI
KINNKTGEIVEEYNSGLSQTIEGMGPLIYYLKSIDEKLENRIINLKSWPT
NNAKKGYFEGLEIKTYTLLENMTESPYPSEIYELANELFKNHAERKHYIN
NLIKELKLSTSIATNLTGRFRIKDRQSYTVKDLFEIYKHYKYDLFKFSNS
FVLGLKYKSGFIRGKEETIIFTSYNDLEYLKSTIDF
>SH2333 N-acetylmuramoyl-L-alanine amidase
MMKTQAEINKRLDAYRKGTVDSPYRVKVWTSYDNRFYPMEPGCIDVDKSF
HAQCADLTIDYILWLTDNEFRIRGNAKDAINPKKNKLPEGWKIVLNRPST
VPRKGWIAVFTDGTYWEYGHIGMVYDGGNTSRFQILEQNWNGWANKKPSL
RWDNYYGLTHFIVPPVAKENKAVSSSKQQAPKQKVKKASTKKALPKITKH
ITGYNMDKRGYNPKGVVLHNDAGGMNYKQYYNNLVNANYDRLARGIAHAY
VDRTGIWEAIDESRIAWHVADGTRPGSGNHDFYGIEVNQSLRASDKEFLE
NEQAVFQFAAEKLKKWGLPANRNTVRLHNEFSQTSCPHRSMVLHTGLDPL
YHSITEHARLKLKDYFIKQIRAYMDGKKPTSKVVVSKPGSASTPATRKDA
NGYRENPHGTLYKEEHATFTANANIITRYVGPFTNMPQAGILKAGQTIIY
DEVMKQDGYIWVGYTAYNGKRVYLPVRKWNRETDSVGKLWGVIS
>SH0041 
MTIYNLNFGIGWASSGVEYAQLYRRNIFKLMKENFKFIYLDFIQKENIQT
LTENLGFEDDEIIWIYQYFTDIKIAPTTYTIQNIIDRLEDTNVEIERVNN
KIKKIIFGNDNNYIRCYLKNESENIVDRAEYVSKGKLIKKEFYNFTIVFT
EYYAPYEKKAKLYLRTYFNEDGSIAYEEHISGKNSIFVFPNVILYSKLEF
IAYFLRQLNLTREDILLIDRSKNIGQVILENKNQARLGVVIHAEHFNHSN
TNEDYILWNNNYEYMFNHVDYIDFFITATDAQKQLIVNQFNQYKNKNPKV
YTIPVGSLKELKYTHERASNSIMTASRLAKEKHVDWLIESVVQAHKTRPS
IKFDIYGEGAEKNNLQKLINEKEANEYIKLRGHKNLEEIYKKYQLYLSGS
TSEGFGLTLMEAIGSGLGIIGFDVNYGNTTFIKDRYNGYRIPESIKNQGT
KEIATKFAEKIDEYFVSSNKIDQMSHESYLIADDFLLNNCKEKWLSLVNE
VQDD
>SH0297 
MCTGFTFQAKNGDVILGRTMDYDYPLSGHPAVQPRHYYWESRVDYKGTTT
YGFTGAGSDMEGFIFGDGVNEHGLAISNQYDRGYASYANKIHDGYINISQ
TEVLTWVLGYNKTIEELIEQADQVNVVAHTLNDINEAPPLHYHVSDATGR
TAEITFVEGRIVLHDNPVGVLTNSPDLNWHYENLKNYANVTPYKPQYKRY
KNLYIGNESGTSGLPGGYTSAERYVRAAYLVSNMLPDDGDDAVLDAFRIL
DSVSIPKGAVRPSEDEFHYTLYQTVFNLTSRTLYVKYYNSNRIAELQLTE
ELLNSDDLVIFDPIPQGLSTDKVN
>SH2633 
MNQVKNVLSSLFEPLTKIETYENLAIKIALIIIYIIVALIVIAILNKVIE
QAFKIQNRSSKGNKKRSRTLISLVQNVVSYIVWFIVITTILSKFGISVEG
IIASAGVVGLAVGFGAQTIVKDIITGFFIIFENQFDVGDYVKINSGGTTV
AEGTVKSIGLRSTRINTITGELTILPNGSMGEITNFSITNGFSIVEIPVS
VEENLDKVEKRLNKLFTAMRSKYYLFITDPVVEGIDSLDETKVTFRISAE
TIPGEGASGSRILRKEIQRVFVQEGIKLPQPIYIKNNNQQGKS
>SH0486 
MKKTVIASSLAVALGVTGYALTTDNSAHASESTTNYAQLANLAQNNPSEL
NAHPVQAGAYNITFVKDGFKYNFTSDGQSWSWNYTYVGGADTVATTQAAP
AAQSTDYSASYSNEASTQSVSSNQQSSNTNVEAVSAPKTTSYSASTSSSS
SASTGGSVKEQFLANGGTEAAWNAIVMPESGGNPNAVNPAGYRGLGQTKE
SWGTGSVASQTKGMINYANSRYGSLDAAIAFRDNHGWW
>SH1347 
MSAIEWLFILLAIFLVLTLEAVNTAIECVVDLVTMDYHELAKQAKDIAAF
SVMLVSIFALITGLVVFLPHIF
>SH0344 
MTVLLTGATGHLGSHITEHAIKEQVPDFNIGIRNPDKMPSHWKDKVGVRE
LDYFNEESMVRAFKGIDTVIFIPSIIHPSFKRLPEVENLVSAAHKVHVSH
IMFIGYYADQHNNPFHMSPYFGYAERLLASSGLKYTYVRMAMYMDPLKPY
LPELADMQKLIYPAGEGRINYISRDDIARGIVALLQQPDKFGHRYLLSGY
SYSMTELAAILSEAAGSKIEYSPVSLEKFSEMYDEPKGFGALLASMYEAG
ARGLLDQHSNDFEQLVHDKPQTFPEFLKK
>SH1721 
MSKILLTGASGYIGGHLKDQLKIHHDIIATSRNTSNKENEENVTWKAADL
FDLDEITEVMEGVDTAIYLVHSMMPNAKLTQANFEDMDALLADNFARAAK
KQGVRHIVFMSGLIPNEDKLSAHLRSRLECEKILGSYGIPVSTLRAGLII
GAKGSSYPILKRLVERLPGMVLPSWAYNMIAPVSINDVINKLALLVERTP
QHNESFDITGPEIMNYKELIQRTAVVLNKRLPIVDLPIIPIWVSRYWVQL
ISKVPKEMVYPLMNSLVHDMIPQPERTHPDISIGEMTYEESVQQALDEEN
EMNENQNKSKKSSSSNSKEQIKDVRAISRFRIPENYSMEDVSKTYAKFIN
NITLHLINGTINENEFNISLPFTNQFILKMERDMQDSSKDMIVYKIVGGN
LALSNNGGNARFEFRRILDSNEAIIALQEYEPTLPWSVYKFTQANIHKSV
MELFVNHMNNLADKDKEATTQSDQLFSTIAMTTGAVIGAYVGSKIYHLIK
A
>SH1468 
MQTVLIIGANGKVSIEATKLFLEDSNFNVDLFLRNAHRIPDYASNRVTVY
EGDAKNSKDLEQALDKVDVVFASLSGSLDIEAQAIVDAMSKKDVKRLIFV
AAPGIYDELPAKFNEFNKSQFGDKLTKYRKAADIIEASTLDYTIIRPAWL
TFKNETDYEVTSKDTQFRGTEVSRRSIASLAVRIAKNPELYSKENIGVNK
PNTDGDKPAWFK
>SH1454 
MKIGITCYPSMGGSGIIATELGIKMAERGHEVHFITSNIPFRIRKPLPNI
TFHQVEVNQYAVFQYPPYDITLSTKISEVIKEYDLDVLHMHYAVPHAVCG
ILARQMSGKDIKIMTTLHGTDITVLGYDHSLKGAIKFGIEQSDIVTSVSH
SLAHQTKSIIETEKEIVPIYNFVRENEFPTRHDETLKEVYGIKPDEKVLI
HVSNFRKVKRIDTILETFAKVRKNIPSKLILLGDGPELLDMRKLARHLGI
DSDVLFLGKQDQVSEFYQMSDLVLLLSEKESFGLTLLEAMKTGVVPIGSN
AGGIKEVIKHDETGFIVDIGDSTSASEYALQLLSNKELYNKMQTAMLKDI
DERFGSELITDQYEHYYRKMLNQKED
>SH0207 
MKRVIMTANFGAVGFSNKDKSSVTTEEHWTNPNEKGFSVYEKSKLIAERA
AWDFVNATENHIEFATINPVAILGPSLNQHMSLSFQFVENIASGKMKRIP
NIPMNIIDVRDVAQLHVLAMKTPEANGKRYIATADGQISMPEITQLIKKE
RPELASKVSTKTIPDFAIKLGARFNSEAQEGKLLLEMNRNVSNQQARNVL
GWTPSYTQEEAILASVDCMRDYHILK
>SH0463 
MQCPNCGQTYQQGDQYCGSCGNKLNGSLSQSTQSTTESFNSEIQSTSHST
AIKQEQINGEQNHSEYDRGEFAHRYMSYEHRYAEGPFTIKVKSTFNESKQ
LLKQAFTSHDVVMKGNKSFSITLLSSLVIIGLLILGMLLHLLSASLFDGY
FVDTATIILKFVLTTMLALAFLFIVTFAVIRLMIVESISFKKILSDYILV
NTLSVSILFLGFIVFFFEMYIFSGILIAFSVILLLTSSVYLISKYSVNHT
LRFASFYSVMIFFVIIGFALHLFGSTIIHRYDDLGILHQLFWRWL
>SH2280 
MKTFFTPLRILIATLTLLVISFVCYIYAKIPTEPDTSKIETITAKPQYSL
SFIGEQQPQESFTLYFNPSLGNVSSLLVKNDEIIHSDTPLFEYYNPILEK
LIVAKKKALSSLINQSTKQSISQQLTLNSQILELQSRLQIRINSPISGKV
TILEAHPSKLNTKIMQINSEKHIIRANITESQLEHIKVNQDVNVTRNHSK
LFTGKILSIIQIPYKVEKGESIYQVDISTQDQYPLGRHFDIDVGTSKIEL
PKNSIYENYYVLITQNNKIIKRRIEYTKSQNNGYIMVSNGLNIGDKVIVN
PSSSLLQK
>SH0489 
MTKLESLLHASTGLSLISGYLMYNRRYLLSFDKKREGETTQSISVIIPAR
NEEKRLPKLLKSLSQQSMRVECIVMDDDSNDRTAEIAREMGAKVYNVTYD
NNGNTWIGKSYACYLGASYTVSDILIFMDADVELNNEHALEAIIQSYARQ
QYRGLMSIQPYHVVYKPYEHLSAMFNLMTVVGTNSFSTLSKSKGESLAFG
PVTVMNKSDYILTQGHKNAASHIIEGFSLGKAFQRCQLPVTRFEGQGFVS
FRMYEAGFKTMIEGWTKHLAVGASSTQPHIMMLIILWMVGCITSFSGLAL
SLFMKTLSFKRMALSYSLYTLQFIRLHRRVGRFSILFLAINSILFLVFIL
VYINSYRHIHYTKQVKWKGRQFSIK
>SH0122 
MSQFKDTLYKLFEPMMKIEFYQNLLVNLLIILAYILIGMIVIAISRKLVT
KFFNVNEKKKNRHKIKRSETLSTLIQNLISYVVWFIVLTSILSRFGISVS
AILAGAGVVGVAVGFGAQTIVKDIITGFFIIFEGQFDVSDYVQINASGVT
IAEGTVKTIGLRSTRIQSDTGEIYTLPNGMISEIVNYSATDVSPIVMIPI
SPNENYKVIEEKLLRFLPTLKNKYDIFVSAPELLGLDSVDGNEMVIKLLA
HVKPGMHFPGQRLLRKEVIQYFSEEGIHIPKPTLVKLDKELSKKE
>SH2236 
MKPNVLLAGGSGYIGKYISSVIEKDANIYALSKYPNTKKEDNDRIIWLKR
DIYNYTDVVKAMEGMDIAVFYLDPNKNSAKLTQATARDLNLIAADNFARA
AAQQGVSKIVYISGSRFDIETVQRLENYGVPVEKTNTQIKRPHINAELQM
SKYDDIRTAMRMILPRKWTLSYLVDYFMKWLNDTRGTFMHTYQDNDRYIV
YARKKSKPLLIMEKVEDDSGLITLHLISGSMIKSNQKKQGKLEFRQIKGT
RLVIVHLYDYIPKLLWPIYYFVQAPLQGLIMRGFEIDCRIKHFNGRVQSG
EKMKYTK
>SH2229 
MKKLAVAASVATGAVAVLSNHNAEASTQHTVKSGESLWSIASKYNTSVDS
IKKSNNLSNNMIFPGQVISIGGSSNNSNNASSNATTSSSTYTVKAGDSLY
AIASKNGVTVNALMEANNLSGYLITPNQKLKIPNGSTTTPSKTNPSTNNN
VGGSGGYSSPTFSHQNLYTAGQCTWYVFDRRSQAGKPISTYWSDAKYWAG
NAAADGYTVDHNATVGSIMQTTTGYYGHVAYVERVNADGSILISEMNYAN
GPYNTNTRTIPASVVSSYNFIH
>SH2547 
MNKKILATAVLGTGALSTLFAHQAEASTTHTVRSGESLWSISHHYGITVS
KLKSLNGLSSNLIFPNQVLKVSGSSNYSSRSNYGNSSSTYTVRAGDSLSS
IASRYGTTYRHIMNLNGLNSFLIFPGQQLKVSGSVSSNSHSSYNSNSGGS
SSTYTVRYGDSLSSIASRYGTTYQHIMRLNGLNNFFIYPGQKLRVSGSAS
SNTYSTRSAQSTYYSSPVFNHRNLYDWGQCTWHVFNRRAAIGKGISTYWW
NANNWDNAAARDGYRIDGNPTVGSIAQSDAGYYGHVAFVERVNSNGSILV
SEMNFSASPGILTYRTIPAYQVRNYKFIH
>SH0239 
MQIIKQDGSILHIYFENPINKIEKLYIKNEFNSLTLEKTNGDLHFKIDLV
EVAKQFIQYENKKIYIIVEESTPILTTQSNLKVTNSQSEVSGLTEVLIDD
SENIKIQPYITRNGYLHLSLDDVDLNKTYFSRRHIDTLKINNSEAIIEGQ
FATLNSTLKDVQLLIKTRLTDREKFVNINLEEIGKTKNASTYNFSVDIYK
DLIEFMKYEYKNEDIIDIYLSIKVLESSENLRIKIGNPRIMAEKLLKGEI
ITEFNGNIVSLTPYFTMKGRNLSFRINTYDIDSYLTYVDELKRPKRPNFL
KKENQKIWVIGEKSYKAQDNGYHFFKYMRTYHPDKPVYYIIEKDSKEAEN
VLPFGNVIFYNSAEHFKIMIKADYICTTHHPELIYPTTSDIYTRKIKAVK
VFLQHGVLGTKNLSNINGNQLKDFNVDLFITSSSREKEIVVRDLNFFSNQ
VAVTGLARFDELFNPNVEVKNQILIIPTWRDWLTSIDRLQTSEYLKRMND
LLHSQKLKEIANKGTDIIFCLHPNMQPFIDYFDVPSYVTSIKQGDIDVQK
LIKESKLMITDYSSVAFDFSFLNKPVIYYQFDRNEFLGKEASHIDIEKEL
PGIIVNAQDKLERELDNIQKKQFKIDEALEKRIDRFIAYKDRNNCERIFD
SITNFRETSKVKSKIKYDILSQHAVNRFRKDKKYFKVMEKFNTGLTRLLP
VKKDLIVFESNVGKLVGDSPKFIYDELKKYNKKYQIVWATNTLYPFNDPN
VKTVKRLSPEYFYYLSRAKYWINNQNFPHYLRKHKDTIYIQTWHGTPLKK
MLNDVETFQGRDANYKNRVNQAIKNWDYLISPSPYASACFKTAFDFQKEI
LEVGYPRNDVFYNVENTDMTEKKKLIKQKLGIEGNKKIILYAPTFRDDEI
NKAKKHIINLKLDLPRLKESIGDEYILILRPHIIISNALNLSESLKDFVV
DGTKYPDISDLYLISDICITDYSSVMFDFANTKKPLLFFTYDLEFYKNKL
RGFYFDFEKEAPGPLIKTNDGLIEAIKNITNVQEEYDDKYQVFYNRFCTF
EKGIASKTIVDKFFKQDC
>SH1036 
MLINAQDYGLKGCNKRKDTKAIQRALNKARYGEHTVLIPSGTYYISKALI
IYDSTTLLLEDDTTLLRCGKDALLKNGHRFGFYKGYQGNSHIYIKGGTFD
MNGSKYPYNNTAMSIGHAEDIQLIGVTVLNVVGGHALDACGINGLYIKNC
NFKGFNDFDGDRSFSEAIQLDIQVPGAFPKFGTTDGTITKNVVIENCYFG
NSDDHQMRPWNRAIGSHASRYNKFYENVHIKDNCFEGTEDYALTPLKAKN
MIISRNKFKNCKGGIRFLGVKDGKNAADPVTGKVMESQAGENFSVIGNHF
IGEMKKDAIHIRSYNNVKHQQVFIAGNTFDKASQTIHLEDIEDLTLNQGE
DVTIKKINVD
>SH2251 truncated poly (glycerol-phosphate) alpha-glucosyltransferase (teichoic acid biosynthesis)
MKFEDTINPNSQKVSKRKVFTLNGRLHKIDYFDDVTAIKIKEEYYDKKGD
VYLKKHFTNDEENKLIDIEHLTKRGETRTFNNEKALFTYYYNHVLPNGSV
VFNDARLLDRPLIDCENDIKRILMFHSNHIQGNKVCHSYKLALDKQEIID
KYIVLTEYQKHDIQSQFGIDDNKIDVIPHFVSIAQSNRRDEVEDQFCFIG
RLAQEKQIDHIIKAFDIYLKKGYSSKLLVYGKDKEGNLNTLKQLVKTLQL
EDKVIFKGHTNHPKEVFSKVIASLLTSRYEDFGLSIMESINYGCPVISYN
VRYGPSELITNHENGILVKKDDIEGFADAMEMARNIHFKDVKLSEKFSVE
QASNNYQSLIDDVTHAENK
>SH2629 
MFKKTTSSIACLTIMATSIGALNANASEQTEGSQKGTMGYGYQKYLKNHP
NEQSNATSNRSTFSTKSKAITTQNGDRVLDISEWQGNLTDSQVKQLKKDY
DFIIIRGQYGSEYVDQCLENNSALLDKNNMKFGVYSYSLYENADDARNEA
QTLYSRAPKASFYVNDFEQNSITSGDADTATKAWADEMKQLSGNKKVLFY
SYENFMTNNVPNAVSAYDGYWLAAYQEQEPNREKVLWQYTDSYYAPELNQ
NVDANYIDANVTADWFTS
>SH1652 
MSYLITIVSFMIVFGVLVTVHEYGHMFFAKRAGIMCPEFAIGMGPKIFSF
RKNETLYTIRLLPVGGYVRMAGDGLEEPPVEPGMNVKVKLNDKDEITHII
LDDQHKFQKIEAIEVKQCDFKDDLYIEGITSYDNERHHFNIAEKAYFVEN
GSLIQIAPRHRQFAHKKPLPKFLTLFAGPLFNFILALILFIALAYFQGTP
TTSVGQLADHYPAQQAGLKSGDKIVQVGQYKTKSFDDIQSAANKIKDNKT
TIKFERDNQTKTVDITPKKQVIKQTKLNSETTYILGFQPEKEHTLIKPIA
LGFDQFVSASTLIFKAVGTMIASIFTGQFSFDMLNGPVGIYHNVDSVVKQ
GIIALTYYTALLSVNLGIMNLLPIPALDGGRILFVIYEAIFRRPVNKKAE
TIIIAAGAIFVLIIMVLVTWNDIQRYFL
>SH2450 
MERIVITGALGQIGTELVLKCREIYGNDNVLATDIREPEEDSPVNNGPFE
VLDVTNREAMMAIVENFKADTLMHMAALLSATAEKNPLLAWDLNMGGLMN
ALETARTYELHFFTPSSIGAFGDSTPKKDTPQNTIQQPTTMYGVNKVAGE
LLCQYYFTKFGVDTRSVRFPGLISHVKEPGGGTTDYAVEIYFEAVRKGRY
TSYIAKDTYMDMMYMDDAIDAIIKLMEADSDKLVTRNGYNLSAMSFEPEQ
IKAEIQKHYPGFALDYEVDPVRQAIADSWPDNIDTSYSRKEWGFNPKYDL
AGMTELMLKAIEEKEQNK
>SH0303 
MFGKFVKGIGIITTISLLHTSISDASESPVTIANKEKNSSISTKYQPSGV
MLTTDQGQILYNYRGNNQVDPASMSKMMTLYLTYEAIENGKLKLNDKVKI
TNKYATMSNLPNLSSVSLKQGQTYTIEELIKQTTLASSNAAAMILGEKVS
GDNNTFTNKMNQQAKSFNMTNTNFVNPAGAQNSLLDQYAPSKFKKQDFPK
STAKDMNLLMQALIKKYPQILQISKLTRDTQRGNTFKSTNLSLKGQPLYL
PGTDGLKTGTSNKGYNIALTNKQDQLRLNETIMNVKPFGDVNAKYNRNRI
GNQIIKQYRQKYEYKKVLTEGDHEIDGNKYHVKKDLYDVVPKDKSKWHLA
INSKGKVYVHYYRDFLPGSHYPRVAADKKWKWF
>SH2419 
MSQFTNYKLILEELDRTLSHVQDEQYDRFANDVNGAQRIFTAGKGRSGFM
ANSFAMRLNQLGKEAFVVGESTTPSIKEHDLFVILSGSGSTEHLRLLAEK
AQSIGAKVVLLTTSPDSPIGELAETVIELPAGTKHNVEGSEQPLGSLFEQ
SSLLFLDSVVLGLMETFDISEEEMQNNHANLE
>SH0518 
MTLIQAILMILLTVVMYFAAKKLQQKYDNPFLNPALVGSVGVIIVLLLTH
QNYHDYMTGGKWINHLLNATVVCLAYPLYKNRHKIIENLSIIFSSVMVGV
ILNFVLVFTSLNLLGYDEETIVTILPRSITAAVGIEVSQELGGTDTITVL
FIITTGLIGSMMGSMLLKVGNFKTSIARGLTYGNASHAFGTAKALEHDNE
SGAFSSIGMILTAVISSILIPIMIILFY
>SH0206 
MKEQVLVTGGTGFLGLRIVAELLKQDYSVRATIRSLSKKDTILETLKAQN
IDT
>SH0692 
MKSFTFFMHNIYALGGTVKAVSELANTLADKGHHIEIISVFRAQDEPYFK
INDNIKIKTLVDYRLKPQNTKAIMMNRLNKYTSLLKPKEINQFEPGLNQF
SKYVEHKMIKAIKKVDTDVLVGTRASFNILISKYHSNDVITVGMEHMNLH
AHPENYQQDILTAYRNIDLVTTLTQQDQLNYEQQIDTPVYTIPNIINPVK
HATKKENIIISAGRLEFEKGFDILIESVRRIQNDLKQLNFKVEIYGDGQE
RGHLQQLIDQHQLNDLITIYPATQQLNTKLSNSKITVVPSRNEGFGMVLL
EAMAQDNIVISFKDTLGPASIINHNSNGYLANYGDAGSLAKYIDIAMNHV
DEASQMINEGHVTLKQYTPNTVYEKFMTAINNV
>SH0140 
MAKLVSIIVSVYNKEQFLEKCIESLIDLKMDKNNIEAIFVDDCSTDESVN
IIKHYEKDYDFIKLIQLPENTGSPSEPRNIGMREAQGKYITLLDADDWLD
KEGFPQVIEKVNKDDADLGFGQSFKHKSKNVKYHARFTSYKEASHLKPQD
ISKIFRAVGPPGKVFKRSLVMDHHIEFEHMKYGEDKLFFFQLFGKVDDIT
MSTIPMYHVNRYDENKSLVQQTSMLDKANSNLEVLDRTCHMDMSSELKHM
ALARMVEVDFISRFLRTKTFIKSADKEKFYAVIEKVERKIKEQGIDINTL
ITNPVFKQIYTLYHHADESVFVNFTKDVVNDQWRYIIQDGIVFRDFVHQY
DMIKPTVVDCYPVYEGTQMMGENKYEVIRVMKPDDINIQSVSLVEINNAA
NEYEVTYKYSDDRIYVPHEEFEKLNKDININFNVNYGESGRSLVYASYPS
FNDVFKMKRQNFKVEFVHKKNENKAQQVTNRKSEYFKRITNPMMTLKKIK
IYKDVSFKEEVGSLEAGTRVEASDIQYTSKGTPRLVLDDGSIITANKDFI
TLINTSGLNKYITEVPKKVKVVKACKLYDSRDFKDNTVRKLKKGDVLTIR
DIIYTNNSTPRLVTQEGLFLTANKDFIKIIK
>SH0690 
MIKQINISNMRHLALQLNKAKSAGFSHFIPYSNDIKINHDMLEAIDLTHN
SIAVDYTLNGLYLNDCRYFGEDTLTFLSWMKNINHYPNIIFNIDRALLHL
SKYDIQSIMDLAVISVLKDEIDIDNHVVFDFINECRTSHAFWASLDTFDI
KKINHFDLNKLAYIHGHSIPYSKFRYPGKEEEMRFVDSWLVTTKFKLPKW
LYNKMQNRALNKHRNLSYVYDKDSSKVKNHVVFLGFDYGYRGNSKYLFNY
FVKRNPTTEAYFITNDRRGPYFLPTDAENNKELIETAKIVVIESYIPDDF
KPNGTVIQLWHGTPIKKLFLDSKEPDQNKNIYNYKARKYNKWLKQDYLLT
DSESAEGLFETAFPNQHTQMIPYGYPRISYLLHYQNDKNHQKKIKDALNV
DRTKPILLYAPTWHATKDSTELMSISPELIEEYHVIFKGHIEDDMTLPEG
AIEAPNHIETQDLLLISDVVITDYSSIIFDALTIGKKVCLYTPNHSSYQQ
ERGVYDDVMESLSKVWYTDEDLLHNNLIHHTLTDISKHQLVNRNNTSLKR
LTQLMRDIINNK
>SH0096 
MKSLIIGANGGVGQHLVRKLKARDVDFTAGVRKEEQVEALKADGIDATYI
DVAKQSIDELIELFKSYDQILFSVGSGGSTGDDQTIIVDLDGAVKAIKAS
EQIDHQHFIMVSTYDSRREAFDASGDLKPYTIAKHYADDYLRHANLKYTI
VHPGALTNEHETQQFNMSAQFENVQNPSITREDVAEVLVSVLTDEVLQGH
EFQIINGDLSLLDATTKYLEE
>SH0618 
MTKIFITGATGLIGTRLTKRLVEEGHEVAGFTTSERGKEKLERLNAKAYI
GDILKADTIDAAIGDFRPEIIINQITDLKNVDMAANTKVRIEGGKNLTDA
ALKFDVKKVVAQSIGFMYEPGEGLATEETPLDNHSDGDRKITVDGVVGLE
KETARMDQYVVLRFGWLYGPGTWYGKDGMIYNQFKDGEVTLSDGVTSFIH
LDDAVEVSIQAMNFDTGIYNVADDEPVTGSDFAAWYSKEVGVDPKVTIQP
AQPFERGITNDKFKEQGGTLIYNTWKDGMHPLK
>SH2316 
MIGKCGNSGNSSEPHLHFQVMNTSKIDECVSLKIKFSNGRSPIKGDSI
>SH2179 
MSLHKKKISLFAFFLLTVFTVTLKTYFSYYVDFSLGVKGLVQNLILLMNP
YSLIALILSVFLFFKGKKAYWFIFIGGFLLSFLLYANVVYFRFFSDFLTF
STLNQAGNVESMGGAVGASFKWYDFVYFIDTIVYLFILIFKGSWLDKRVF
SKKFVPVVMAASVALFFLNLAFAETDRPELLTRTFDHKYLVKYLGPYNFT
VYDGVKTIQNNQQKALASEDDLTKVLNYTKQKNTTPNSEYFGAAKKKNII
KIHLESFQTFLINKKVNGKEVTPFLNKLSTGNEDFRYYPNFFHQTGQGKT
SDAEFTMDNSLYGLPQGSAYSLKGDNTYQSLPAILDQKQGYTSDVMHGDY
KTFWNRDQVYKHFGIDKFYDATYYDMSDDNIVNLGLKDKPFFKESAEYQS
KMKGPFYSHLITLTNHYPFTLSEEDADIDKPNTGDSTVDGYIQTAHYLDQ
ALEEYVTDLKKKGLYDDSVIMIYGDHYGISENHNNAMEKLLGEKITPAKF
MDLNRTGFWLKIPGKEGTVDKTYAGQMDVMPTILHLVGIDSKNFLMFGTD
MLSKDHNDVIPFRNGDFITKDYKYVNGKAYSNKTNELLETQPKDLDKNKK
QVEKDLEMSDNVLNGDLFRFYKNPDFKKIDPSKYEYKTGPKGNQK
>SH0332 
MTVYNINFGIGWASSGVEYAQAYRSKLLREINQPAKFIFLDFISAENIQT
LTDNIGFKDDEVIWLYQYFSDIPIAPTTYTVDDLKKDLGNPVTAQVVTGK
TMRLYIGNDKSYVSCYLKNEDDIIVDRAEFVVNGMLVRKDYYSYVRTFSE
YYAPYENRAKLYKRQFYNEDGSIAYKEYIDGESSVYVFEDARLYSKQEFV
AYFMKKLHLTEQDIVIIDRSTEVGQSILEHKGSSKVGIVVHAEHYSENAT
NDTYILWNNYYEYVFAQAPYIDFYITATDLQNQVLSEQFQKYTSHQPRVR
TIPVGSLHQLSYPIGERKRYSMLTASRLASEKHVDWIAKAVIKAKKKVPK
LTFDIYGHGNERSKIEEIIKENEAQDYIQLKGHKKLDEIYVNYDLFVSAS
TSEGFGLTLMEAVGSGLGMIGFDVNYGNPTFISHGENGYLIPIDKDNQDV
EVITNLMAEKIVQYFNDGPKHSHEKSYKIAESFKTEHITQKWQNLIDEVL
YD
>SH1271 
MQKFFKNNKLIVVFCAVIIFIALIGLSLRSHTQSPPEQYVGDSVSLGQRV
VSYPVNFVTGAINNLFSSNKTTDNKKIKQLEAKNEKLEAENKDLKKELDM
TDISKYDPISGAVIARNADQWMNTVIIDKGNKDGVKSNMAVMTAEGLVGR
VTKVNQFSAQVDLLSTNTRTGKLSVNIQHDSKNVFGLIDHYDKKNQELII
GNINNKNKISKGDKVVTSGLADQLPSDLYIGEVTKVENDEYGLAKEVRVK
TGANLSDISHIYIAKKDPDNASDESRDN
>SH0375 
MVKYYVSCLVLFFTFAIICGMALAEDVTDEASVVAVGDNLIHPVVYNDAL
QQDGSFNFKPMYSHIKNDIQSPDLAFINQESPIGGDNRPFSGFKNFNTPS
QIAQDVVETGFDMVNGANNHSLDQGDEGVLNHLKTWNKFDKQVLFTGIFN
SEKDAQTIPVMTVNGIKVSLLSYTYGTNEMTSQYPYTIKKFNEKTIQRDV
SQAKKQSDVVMVSAHWGLENHHEPNRTQRKYAQLFANEGVDVVIGTHPHV
IQPIEWVKSEHGHHQTLVAYSLGNFLNGQDTGNEHNQLLGRLNFDIVKAP
KGAHIENVKWTSMVNHYQQWDETDKDTRHDFEVYNLDDYNEDLAQQHGLR
HDNKSQWNVKHLQDITKDVIDSDYLDEKSI
>SH1942 
MVTQNKKILIITGSFGNGHLQVTQSVVNQLNEMNLSHLSVIEHDLFMEAH
PILTSICKKWYINSFKYFRNMYKNFYYSRPDELDKCFYKYYGLNKLINLL
LKEKPDLILLTFPTPVMSVLTEQFNINIPIATVMTDYRLQKNWITPNSHR
YYVATDDTKRDFVNAGIPASDIKVTGIPISDKFESDIDKVAWLKKHNLNP
DKPTILMSAGAFGVSKGFDYMIDNILQKSPQSQIVMVCGRSKGLKRTLEM
QFKSYDNVLILGYTKHMNEWMASSQLMITKPGGITISEGLTRSLPMIFLN
PAPGQELENALYFQDKSYGKIANTPEEAIDIVSDLTNHEYRLQAMTNKMT
EEKVNHSTYRLCTDLLNILDSSSQQQEIYGKVPLYARFFVK
>SH0040 
MNKNSKKKLDFLPNKLNKYSIRRFTVGTASILVGATLIFGVANDQAEAAE
NNTTQKQDDSSDASKVKGNVQTIEQSSANSNESDIPEQVDVTKDTTEQAS
TEEKANTTEQASTEEKADTTEQASTEEKADTTEQASTEEKADTTEQASTE
EKADTTEQASTEEKANTTEQASTEEKADTTEQASTEEKADTTEQASTEEK
ADTTEQASTEEKANTTEQASTEEKADTTEQASTEEKADTTEQASTEEKAD
TTEQASTEEKANTTEQASTEEKADTTEQASTEEKANTTEQASTEEKADTT
EQASTEEKADTTEQASTEEKANTTEQASTEEKADTTEQASTEEKADTTEQ
ASTEEKANTTEPLTDNQDESTEDESIEAKKALLTEYVTSNSDVSEEEAKA
EIQDIDLQDVDFSNANENTLLSTLVKNISNKKEEDEKLATPRAISRIASP
VMLAATDNVAAQESGTNVNNKIDVTSLQTDKNTVRPNDGEGFSVTSTFKV
NGKVNEGDYFTVDMPDYANFNGIADYTAVDNKIYPTIKDGEQVVANGVYD
VDTKKLKYTFTDYVNNKQNIEGGFKLPQYIDRKTATQSGDYNLNYNVAGN
EVNIPISVQYDNYRDGHVIANATSLITNADIFNTGSHEYTQYIYVNPQSV
NSYDTWLTIQGYQNQVNDSSAIFNSNDTSIEIFDAESSSNINPSFYVNDS
NYRNVTSNYQINETGDKQAKIYFGHIDHPYIVKVTSKIDPNSTADLKTRI
RMDNKNYRGTTDYYIHDNTVERSGANGIAQGDEALYNLGDYVWEDTNKNG
IQDSDEQGIEGVTVTLTRPNGTTETTTTDSNGKYQFSDLQNGSYVINFQT
PEGYTPTKSYQGMNTEVDSNGLSTVGIINDADNWTLDSGFYKTPVKYSLG
DYVWYDSNQDGIQDYEERGIEGVTVTLTHPDGTVETTTTDSNGKYQFDNL
DNGDYTVHFEKPTGLTQTVVDSGNDDAKDADGETVKVTIKDHDDFTIDNG
YFESTSDSESQSDSESTSDSESTSDSESQSDSESTSDSESQSDSESTSDS
ESTSDSESQSDSESTSDSESTSDSESTSDSESTSDSESQSDSESTSDSES
QSDSESTSDSESQSDSESTSDSESTSDSESQSDSESTSDSESTSDSESQS
DSESTSDSESTSDSESQSDSESTSDSESQSDSESQSDSESQSDSESTSDS
ESTSDSESQSDSESTSDSESTSDSESTSDSESQSDSESTSDSESQSDSES
QSDSESTSDSESTSDSESQSDSESQSDSESTSDSESQSDSESTSDSESTS
DSESQSDSESQSDSESQSDSESTSDSESTSDSESQSDSESTSDSESTSDS
ESQSDSESTSDSESQSDSESTSDSESQSDSESTSDSESQSDSESTSDSES
TSDSESQSDSESTSDSESQSDSESTSDSESQSDSESTSDSESQSDSESTS
DSESTSDSESQSDSESTSDSESQSDSESTSDSESTSDSESQSDSESTSDS
ESTSDSESQSDSESTSDSESHSDSHLPDTGEEESNKSGLIGAGLAALGGL
SIFGRRRKKNSEQ
>SH2383 
MKISGQAQYIKETNQEKFYNGTTGFQAGEFTVKVKNIEFNDRENRYFTIV
FENDEGKQYKHNQFVPPYKYDFQEKQLIELLTRLGIKLNLPSLDFDTNEL
IGKPCHLVLKWKFNKDEGKYFTDFSFIKPYKNGEGIINKPIPKTEKQKAE
EKSNSQQTPMTSQDNPFGNNDPLGYEDDLAF
>SH0890 
MSLLVIGANGGVGSKLVKQLKEDQVDFTAGVRKNEQIETLKQDNIEATLV
DVEKDSIEDLTETFNGYDKVLFTVGSGGSTGADKTIIVDLDGAIKTIEAS
KQANVKHYIMVSTYDARREAFDPSGDLKPYTIAKHYADEHLKNSGLNYTI
VHPGALEDKEGTSKIETDLYFDGKGSIPREDVASVLKEVALSENKFINKE
FQVITGNQTISEALSSFE
>SH2136 
MINKTLTVTLTSIAALAGLSGLANAQEYTNSTHTTSQQSNTYNSQVEQET
NLGLTNKDIVKVKDGDTLYQIALSHHLSLEQLYNFNPGVTALIHPGDLIA
VSEKGAAKLENKEINYAQTYAETTAFNQSDVVAQSVSASTTNVTGYNIVP
TSAPTNTMHDSYHSSVNTPVSYQHVTTANQGNRYSFGNCTYYAFDRRQQL
GRSIGSYWGNANNWAYSAKNAGLTVDNRPEVGAIFQTTAGYYGHVGVVEH
VNQDGSVYVSEMNWNGHYNRVTNRTITNTSSYNFIH
>SH0275 
MNDKRKKNNYLVYGISVAIIILITAMAGIFPKAFGANAQHIYNFISNSFG
WLFLLIIFILDIFLISLAISRYGRFKLGSDDEEPEFSFLSWLGMLFSAGL
GVGIVFWGVAEPLTHYLHSPFPKDVPNQSAESARVAMGYTFFHWGISQWS
IFAMAGLIVAYFQFRKKRDGLISTAMEPVFGQAYKRPFRNVIDILAIIAT
VMGIATSIGLGIMQISGGLNHVFHVPNNNVTKIAITVLMVCIFLGSAITG
LNRGVKWLSNINIILGAVLLLFMLIFGDLKFIFESYTLAIGDYIRHFVEY
SLRINPYSGNNAWIQQWTVFYWAWVISWSPFIGGFVARVSRGRTIREFIM
CVLIVPPLISFVWIAGFGGMAVKVAMGGDNIAKLVDKDYTVALFELLSKF
PLADITSILAVVLIFLLIVTSADSTTHIVAGMATGGSENPKVKHKVIWGL
LIGAISVAMTIAGGLTSLQTASVVTGLPFSIILLLMTLSIMRALRREHTK
HFQMSYIDDDKDYSIPLEQREDHNKSNEKEQGKEQNNEEE
>SH1173 
MAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTKRIETGEVVTAQHWKN
GRELEPDEMYQSRVAALLKKIHGSKPLLNMLKRMEMEPITPNIMLKKINA
SLSREVLTHHIIRKSLTYLEEHIPNLDSRFFTVVHGDVNHNNWLLSDRDE
LFLVDWEGAMIADPAIDIGMLLYNYVPEKNWSDWLKTYGVEESIELNKRM
KWYTVIQSIGMVQWYEEQKRFKDMNNWLKFLNEVMNSNLFI
>SH0961 alr1, alanine racemase 1
MSDKFYRSTYLNVDLSAILNNYNTVRTLHSDKTVIPVVKANSYGLGSVKI
AQHLMKNGADFFAVATLDEAIELRMHGINAQILILGVIPLEDINKAIQHR
VALTVPSLQWLQHAIELISDDNEKNLWLHVKLDTGMGRLGIKSLEEYKEV
IDLIQSHPHLVFEGVYTHFANADEPGDLMDHQYEQFETLVTQAEKPKFIH
SQNSAGSLLRNFELCNAVRLGISLYGYYPSAYVKEKVETELQPSAQLLTQ
VVQTKYLKVGESVSYGSTFTATEDIKIAILPIGYADGYLRSMQGAFVNVK
GHQCEVIGRVCMDQMIIKVPDDVKEGDSVTLLDNAYDSPQSAETLAQKQD
TISYEVLCNLGRRLPRIYQVDDEMHVTNELLK
>SH1512 alr2, alanine racemase 2
MTAIWSVDKEAFLQNAIKVKNGNSIMAVVKNNAYHYGLEFAVTSFLKAGI
NTFSTTSLKEAIKVREIAPDATIFLMNAVYDFEKVRHYQIQMTLPSLAYY
YKYKNDLSGIKVHLEFENLLHRSGFRTLEEIREVLNDHHINSNEDKMIIS
GLWTHFGYADEFDVPEYSIEREAWLNIVDTLLDEGYHFDLIHAQNSASYY
REGQKLLPHHTHARVGIALYGSRPYSALNEYSIKQSLTVKGNVIQVREVN
AGDNCGYSFAFEATRDHTRLAVVDVGYGDGILKSRAKHEALIKGKRYPIR
ALMMSHMFVEVDEEVDAQDEVILYNNDIRIDEYTFKGVGANSEQLSAMNH
DSLIKEYR
>SH1911 atl, autolysin
MKKKFNLKFPSMIAITLFGAAFTSQHAHAAEANQNSNNTNNVIDDQQNIE
NAEQAKKEVTNSAQNVSGVQTYQNPSDVKASVATVSKTYDAKLDNLATTQ
QTSQDQQSTQNQSTANTSATNSNSELAKVQDNEQEVSTSNKSDQTTNINN
THSNTDANKQTLQASKNALSSSQVQSNDDTSANSNQNTTQYVNNQIDESS
SNSQQENSLTSSNKNQLNSSSVTPSQSNQVAQSNNQIESKQSSDKKVSTY
SNNDNNATQVNVDQAKTSQEANTKNASASKTTQTSTSNSTQSGYSGFRSV
GGKGGPATSVKTVKRYAAKATTSSLPKYKPQVSSSINNYIRSNNLQAPKI
EENYSSYFPKYGYRNGVGKPEGIVVHDTANDNSTIDGEINYMKNNYNSAF
VHAFVDGNRIIETAPTDYLSWGAGPNANGRFINVEIVHTHDYASFAKSMN
NYADYAATQLQYYGLTPNSAENDGQGTVWTHYAISRFLGGTDHSDPHAYL
QSHNYTYNELYDLINEKYLIKTGQVAPWGTTSSSSSSSNTNKGGSSNSGS
TTTSPKLTVKSNSGLAQIKTDNSGVYTTVYDDKGKATNQVHNTLSVTKSA
TLGKDKYYLVSDYNSGKVYGWVKQGETVYNTVKSPVKVNQSYNIKSGATL
YTVPWGNYNQVAGTVSKSNTAPFKATKSQQVGKATYLYGSLNGKNGWVSQ
AFLSNITKPSSGSKTPTVDNTLKVSNLKNTLGQVSTKNKGTYTTVYDKNV
KANATIGGKTYNITKKATLNNKDYYLISDYNGNTSRGWVPASEISVKTTT
PNKTNATYYDINGNANIYDTPWGTAKQVKATVPSSGKQLKSIDNLKVGNE
TYLHGVINNIWGWIKSTDVKQTPKVNAKFAVNTKATKPSTASTQTVSKVA
QVNANNSGARATVYDKTGKNATKYANRTFNVSKEKTIDGNTYVLLQNTTT
NTPLGWFNVKDLKVQNSSSEQKTSGTYKINNKNNGLYSIAWGTNQQRLDN
KDLANKSFKVSKSVVIGNTTYLYGTVNGKTGWIAKNDLTSSNISSDNGEK
YQYEFIINTTNGYYYDDPSSAKATSLKAFNEQIFQVTNRKVVNGKTWYYG
KLSNGKYVWIKDTDLKKELVKYSKSYRTLNQVVSLQQNAYGAPPQVQRNG
YGWSNATYSEIKNAMNTEKLAKDDTLKYQFLCLDRPQNLSVASLNQLLKG
KGVLENQGQAFSQAAATSGINEIYLIAHALIETGNGQSQLAKGANIVNNY
VTTKSATKYHNVFGIAAFDANPLYNGINYAKQAGWNSVSKAIIGGAKFIG
KDYIKAGQNTLYKMRWNPDHPATHQYATDINWANANAQYLKQLYNEIKAV
GKYFDISSYSK
>SH0388 capA, capsular polysaccharide synthesis enzyme CapA
MENKLDLSNIFKIIKKNWGIWLFIPIIFLLISLIITFLFMTPKYEATTQI
LINQKEKNKELMAQEVQSNIQLVNTYSQILKSPRILDEVAKKDNKYSSDE
INNMLSIDAESDSQILNVNVESKNKKDSEKIANEIAKVVSDEMPKIMSVD
NVTILSKATGTAHKVSPKVPVNIAVAIILGLLVAILIIILKELLDKRIKT
EEDVERELNIPVLGSIQKLK
>SH0390 capC, capsular polysaccharide synthesis enzyme CapC
MIDIHNHILIDVDDGPKTKEDAIALLKQANDEGVTEIIATPHHLSPTFDN
AYENVQQKLNQLSELQETKDLGIKLYPGQEIRISDQVLPQLRKGEAIGLN
HSRYLLIEFPSRGVPHYANRLFFELQSEGYIPIIAHPERNKEISQNLDVL
YNLINQGALAQLTSSSLQGIQGKKIQKISIQMIENNLVHFIASDAHHESQ
RPFIMKSLYNNKKLKKYEKNIENLINNAKYIVNDEDVIKKQPTQNYNDRK
LFGLF
>SH0391 capD, capsular polysaccharide biosynthesis protein CapD
MDKLSARGRLLILIIIDSLIVAFSVFICYNILEPFFEGYSRDLLIVNSIV
LLISHHVFAYIFNLYHRAWEYASVNELLLIVESVTCSIITTMILVPIFTA
HPPFFRLYLITWMMHLILIGGSRISWRVARGFVVGKKLKKKPTLIVGAGR
GGSLLIRQMLRSPEMGLEPVLVVDDDPQKKKLTIAEGVKVQGSIDDIPNL
VNKYRIKRIIIAIPTLKPDRLKEINNICNSTGIELFKMPSIEQVLVGELE
VNQLKRVEVEDLLGREPVELDMAMISKELTHKTIMITGAGGSIGSEICRQ
VCKFEPERILLLGHGENSIYLIHQELNAIYKDKIEIIPIIADVQNGDRIQ
EIMDKYKPYAVYHAAAHKHVPLMEYNPIEAFKNNVLGTRNVATVAKNVGV
RKFVMVSTDKAVNPPNVMGASKRVAEMVVQSLNDENCVTDFVAVRFGNVL
GSRGSVIPLFKKQIAAGGPVTVTHPDMTRYFMTIPEASRLVLQAGALAKG
GEVFVLDMGEPVKIVDLARNLIRLSGKTEDEIPIKFSGIRPGEKMYEELL
NENEIHPEQVYEKIYRGKVRDFSKEEVDAIVSDLANDFKKEKIIKIANE
>SH0392 capE, capsular polysaccharide synthesis enzyme CapE
MFKDKVLLITGGTGSFGNAVMERFLDTDIKEIRVFSRDEKKQDDMRKKYN
NPKLKFYIGDVRDSHSVETAMREVDYVFHAAALKQVPSCEFFPMEAVKTN
IIGTENVLQNAIRNNVKKVICLSTDKAAYPINAMGISKSMMEKVFVAKSR
NVDSEQTLICGTRYGNVMASRGSVIPLFIDKIKAGEPLTVTDPNMTRFLM
SLEEAVELVVHAFKHAQTGDIMVQKAPSSKVGDLAEALLQLFEANNEIKI
IGTRHGEKQAETLLTREEYAQCEDMGDYFRVPADSRDLNYSNYYEDGSEK
ITEAYEYNSDNTNILTVEEIKEKLLSLEYVRTELNNYKKG
>SH0393 capF, capsular polysaccharide synthesis enzyme CapF
MKIVITGSNGFVGKNLKEDLKATTNNEILEVNRQTSSEDLKKYLLEADSV
LHLAGINRPQREEEFKEGNVDFLSEVLEILKENPKKPDVILSSSIQATND
NPYGNSKRQGEGVLEQFSKENGNKVLIYRLPNLFGKWCKPNYNSVIATFC
YKIARDEEIQVNDENVVLHLNYIDDVIKEFKNAIDGRPNIENGELKVPNV
YEVKLGTIAKLLYEFKEIANKKSLPNTENSFEKCLYSTYLSYLPEDKFSY
PLKMNVDNRGSFTEIFKTMDRGQVSVNISKPGIVKGNHWHHTKNEKFLVV
SGTGVIRFRKIGEDEVIEYHVSGEKLEVVDIPVGYTHNIENLGDTDMVTI
MWVNEIFDPNNPDTYFLEV
>SH0394 capG, capsular polysaccharide synthesis enzyme CapG
MEKLKLMTIVGTRPEIIRLSATIKACDKYFNQVLVHTGQNYDYTLNQVFF
EDLELREPDHYLEAVGNHLGETMGNILAKSYEVLAKEQPDALLILGDTNS
CLAAVSAKRLKIPVFHMEAGNRCFDQNVPEEINRKIVDHVSDVNLPYTEH
SRRYLLDEGFQKQNIFVTGSPMKEVLNEYAYKIDESNILNKLELETQKYI
LVSAHREENIDNEKNFLSLMNAINDIAEKYQIPVIYSTHPRSWKKIEERN
FKFHPLVRQLKPFGFFDYNALQKNAFVVLSDSGTLSEESSILKFPGVLIR
TSTERPEVLDKGTVIVGGISYDNLVQSVELAKSMQENDEPMIDAIDYKDT
NVSTKVVKIIQSYKDIINRNTWRK
>SH0397 capJ, 
MDYVGKVGGASSISRQFYEDVKNDENNQWIFLTNKEYVSQKSNIKRILVN
NANKTFLHRFYFETFKIPNIINNIKPDLVLSLQNLGVKPKQNQILYIHQA
LPFQNKLWELSNNPISLVKMLLMKYKLIKDIKKSNHIIVQTNYMKKLIEK
YNNNIIVNLPNFNFASPQTHKDTKDFLYPTNAQKYKGLNYIVDFARILKK
NKQNVYINLTLIGNENKYIENIRKIINKEQLAIRFIGRQNSDEMNELYKL
NNLLFTSQVESLGLPLIEAAHYGCKIFAYETDVTKEVLKNYKFKVFFNKS
NIESKYKEFLSFPPTTIGENINGLNINGILRTNHIIK
>SH0398 capK, 
MNALFLTVGNFRSIHNQGIYQDFIKELSTKCEYVLVVSPVQRREKKSTYI
IREGNVVILRVKIPNITKTNKIEKGISTLLIEKLYAKAINKYFNDVKFDT
IIYSTPPITFSGLIKKLKKTNHSQTYLMLKDIFPQNAVDLKMFRANGLFD
RYFRNKEKNTYKISDFIGVMSPANKNYLLSHNSYISENKVHLFRNSTYDS
SKEINENERISILKKYNLSSNKTTFIYGGNIGVPQGTDAIKEVIKRFNEM
ENSQLVIVGSGTKFKEIQNYAQNIKDVFVLNQLPKKDYDLLLSVSDIGLV
FLDSRFTIPNYPSRLTSYLMLSKPVISMTDENTDIGMEIEKYDCGFSIVN
ENIDKFILDSNKLANDIDLRKQMSINAKKMFNDLFRIEENVREMLNFITK
KEREE
>SH0399 capL, 
MTTDRIFLSRPHMGGTELDYIHDAFEKNWVAPLGENVTEFENSMKNYTGV
KAALALTSGTSAIHLALIESGVKRDDIVFCSSLTFSASANPIIYQGAKPV
FIDSEKDSWNMSPIALKKAFEKYAEKGITPKAVIAVNLYGQSAKMDEIKE
ICDEYKTTLVEDAAESLGADYKGHKSGTFGKFGIFSFNGNKIITTSGGGM
LISNDEDSIAHALFVSTQARDKALHYQHSELGYNYRLSNISAGIGRGQME
VLDQRIQRRREIFEKYDEAFGNIDGFDFQPELPDSKSNRWLTALTIDENK
TGFSALELIDALQKNNIEARPVWKPMHLQPYFESYDYIMVDGVDNSAHLF
DHGVCLPSGSDMTDEQQTRVIEIIKSL
>SH1486 ctpA, probable carboxy-terminal processing proteinase ctpA
MSHNPEEKQSNLDSNHKNESSSNKRIKFKTWQFILLLLGVVIITAGITVA
ATIGISHKISGLTKDERQEIKKIEYAYKTLNNDYYKKQNAGKLSEAAIDG
MVKELKDPYSEYMTKDETKSFNEDVSGDFVGIGAEMQKKDKQIMITSPMK
DSPAEKAGIQPKDVVTKVDGKSVVGKPLDQVVKLVRGKEGTTVKLTIKRG
SQEKEIKIKRGKIHVKSVEYKKKDNIGVFTINKFQDNTAGELKSAIIKAH
KDGVRSIVLDLRNNPGGLLDEAVKMANIFIDKDQTVVKLEKGDDTESIKT
SNDASNEAKDMKVSILVNEGSASASEVFTGAMRDHKKAKVYGSKTFGKGI
VQTTREFKDGSLLKYTQMKWLTPDGHNIHGKGIQPDTKIASPQYQSISVI
PTDKSYSVGDNTKYVKSIKIGLDALGYNVNNDSKQFDTQLESAIKKFQSE
HELSVNGKFDKKTNEKFTQLLVEKANKEDKVLDELINKLK
>SH0426 cudT/betT, choline-glycine betaine transporter
MDWPTFIGTVIVLLVAVTPMMVFPKASEKVITDINSAISNSIGSVYLFMG
LIILFFVLYIAFGRYGNVTLGKATDRPEFNNFSWASMLFCAGIGSDILYW
GVIEWAFYYQVPPNGAKGMSDEALTYATQYGMFHWGPIAWAIYVLPALPI
GYLVFVKKQPIYKISQACRPVLKGQTDKFLGKLVDILFIFGLLGGAATSL
ALGVPMISAGIEKLTGIDGENMVVRSIILLTITVVFAVSSYSGLKKGIQK
LSDVNVWLSFLLLGFVFIVGPTVFIMETTITSFGNMLRDFFHMATWMEPF
GGIKGRKETNFPQDWTIFYWSWWLVYAPFIGLFIARISKGRRLKEVILGT
IIYGTLGCLLFFGIFGNYAVYLQITGEFNVINFLNSHGTEATIIQVMHQL
PFSSLIVVLFLISAFLFLATTFDSGSYILAAASQKKVIGEPLKANRLFWA
FALCLLPFSLMLVGGERALEVLKTASILASVPLIVIFIFMMISFIITLNR
DRIKLETRADKHKEIERRSLRIVQVKEKSDDDDNL
>SH1516 dapA, Dihydrodipicolinate synthase
MPHLFEGVGVALATPFTNNEVDYNALEKHVDFLLDNGVKAIIVNGTTAES
PTLTEEEKEQVLESVIKQVNHRVTIIAGTGTNNTAKSIQASQRAKALGAD
AIMLITPYYNKTNQRGLVKHFETIANEVELPVVLYNVPSRTNMTIEPETV
ETLSHNQYIVAIKDATNDFEYYEDVKSRINQEEFALYSGNDDNVVEFYQR
GGNGVISVIANAIPKEFQALYDAKQSGQDISNDFEPISKLLDALSVDVNP
IPIKALTSHLGFGNYELRLPLLPLEDADAKVLINVFEQFKAGEL
>SH0954 ddlA, D-alanine-D-alanine ligase
MVKENICIVYGGKSAEHDVSKLTAQNVLNAIDKERYLVDIIYITNDGLWK
KKENITEEIKEIESLNMTDIEAGEITILLKESSNGKPYDAIFPLLHGPNG
EDGTIQGLFEVLDLPYVGNGVLAASSSMDKLVMKQLFEHRGLPQLPYISF
LRSEYEKYEGNIIKLVKDKLTYPVFVKPANLGSSVGISKCNNEDELKSGI
EEAFQFDRKLVIEQGINAREVEVAVLGNDYPETTWPGEVIKDVAFYDYKS
KYKDGKISLQIPAELDEEVQMTLRNMALEAFKATDCSGLVRADFFVTEDN
QIFINETNAMPGFTAFSMYPSLWENMGLSYSDLITKLIDLAKERHEDKKK
NKYTID
>SH2020 dltB, DltB membrane protein
MIPYGTFTFFLVAIIVLLPVIILGFLGKRSYIYNGLSTAIMIVVIFSSDK
HNLFGNKYLSIQLISFVIYLIWQVLLIMGYYKSRQKSNTFSKFVIVMILS
ILPLAIVKVLQSSWLGGQQIHFHEHKLIEFVGFLGISYVTFKSVQLIMEI
RDGSIKEIKVGKLFQFISFFPTVSSGPIDRYKRFVKDDKKVPTSEQYREM
VAKAIHMIMLGFLYKYIIAYLINVYAILPLLMNLDGFMHKWLYMYAYSFY
LFFDFAGYSLFAVAVSYLYGINTPPNFKQPFKAKNIKDFWNRWHMSLSFW
FRDCIYMRTLFYMSRKKTFKSQFAMSNFAFFLNFFIMGVWHGLELFYIVY
GIYHGLMFIGYGYYERWRKKHPPRWQNGFTKALSIIITFHFVAFGFLIFS
GKLI
>SH2018 dltD, poly D-alanine transfer protein
MKLKPFLPIIISGILFLAFVLMPASWFTGLVTNKAVANNRISLTDQVLKG
TLIQNKLFSSDKYYPIYGSSELNKLDPFNPALALNHRKNTKPIFLIGTGG
NTDLINAIELAGQYDQLKGKKMTFIISPQWFSTHGVNDRDFAARTTPNQI
NQLFQQKDMPSELKERYAKRLLHFKSASNKEFLKDVVNNHGEVDGNYVSR
FKENQLLKIEAIKTYFSLDKSPLSHVKPVTEPNVSWQEMQDKAVTLGEKR
SSSNNYGIRNEYWEKLIHKKPMNHRKYEFKMNSPEFNDLSLLVDTMHNAS
ADVQYVILPVNGKWYDHLGIERSTREPVYKKIHQTVVAHGGKVYDMSDKD
YEKYVLSDVVHVGWKGWAHMNQHIVQHMKDDKNEHNKDHNKQHEHQ
>SH1431 ebpS, cell surface elastin binding protein EbpS
MSKNNFRDDFEKNRQSINSDDQFEDNTNEFDENSNESNDFDNQSDQQFPP
RNAQRRQRRRNQATNKNRKFGNQNSDSNANGSLDDRHDEDSFNELQHNQQ
ENHLDNEPIHKDDKLSSEKDFNNDASRRNNRHEASNRKHDKDYDNGSLND
DDRHRRNHEEGIDERQDNRNHKDQQNKKSRHGKDAAIAGGAGVAGAAGAK
AAKDKRKKDEHHDSKYNEHKDDRDLNNDNQFDQNRKHDKDLHDDHRDAKD
NHSKEEPKKGNKGKKAAVGAGAAGAAGAAGVAAAKHKKDHKNNNHKDNHS
HNRDHQDDHRNHKHEDGNDGFQAHNGKKKRGLAGILLPLIALLLILAALA
IFIGMYLNNDKKDSNQADNKTEQTANKDNNKDSKDKASNDSDKDKASSDK
DKDKATNDDDSNDKATTDNDSSNNSSDDNSSSSDNSTSSNSSDNSSSSDN
NGNNSNSDNNNGNSQATSNNSSQSNSNNNQSNSSNSGQQTHVVSGNENLY
RIAIQYYGEGTVENVNKLKQANGLSSNNISNGQKLIIPQ
>SH2512 gcaD, 
MQRNAVILAAGKGTRMKSNKYKVLHKVAGKSMVEHVLTNVKNAGVNQIVT
IVGHGAEDVKETLGNQSLYSYQEEQLGTAHAVKMANEHLKEVEGTTLVVC
GDTPLITAHTLQKLIEHHESTHAQATVLSATAQIPFGYGRIVRDEQRRLQ
RIVEEKDASEAQKALTEISSGIFAFDNRVLFSKLEEVKNDNAQGEYYLPD
VISLILAENGVAEVYHTDDFNEIMGVNDRVMLSNAEKALQQRINIEHMRN
GVTIIDPTTTFIGPDVKIGMDTIIEPGVRINGETVIGEEAVIGQYSEINN
SHIGSQVDIKQSVINDSIVGDKTKVGPFAQLRPGSNLGSDVKVGNFVEVK
KADLKDGAKVSHLSYIGDAEIGERTNIGCGSITVNYDGVNKFKTVVGKDA
FIGCNTNLVAPVTVGDGVLIAAGSTITDNVPNESLALARARQITKEGYLK
K
>SH2674 gidB, glucose inhibited division protein B
MNGIEWLAKELSEHGIELSDKQKEQFQTYYRLLVEWNEKMNLTSITDEHE
VYLKHFYDSITPSFYYDFNQPLTICDVGAGAGFPSIPLKVVYPELKVTIV
DSLNKRIQFLNHLAAELGLTQVSFVHDRAETFGKGVNRETYDVVTARAVA
RLTVLSELCLPLVKKGGQFIALKSSKGEEELEEAQFGISILGGVFSDSYT
FDLPEDAGERQMIIIDKRRQTSKKYPRKPGTPNKSPLLEN
>SH0880 glmS, glucosamine-fructose-6-phosphateaminotransferase
MCGIVGYIGYDNAKELLLSGLEKLEYRGYDSAGIAVANDNGTTVFKEKGR
IAELRKVADNNDTDGHVGIGHTRWATHGVPSTVNSHPHQSNNERFTLVHN
GVIENYEELKSEYLSDVTFQSETDTEVIVQLVEHFSNKGLETEEAFSKVV
SLLHGSYALGLLDNQDSDTIYVAKNKSPLLVGVGEGFNVIASDALAMIKV
TNEYKEIHDHEIVIVKKDSVTIKDLDGNVQDRDTYTAQIDASDAEKGIYD
HYMLKEINEQPAVMRRIIQEYEDEKGDLKIDPEIVKDVAAADRIYIIAAG
TSYHAGLVGKEYLEKWAGVPTEVHVASEFVYNMPLLSEKPLFIYISQSGE
TADSRAVLVETNKLGYKSLTVTNVAGSTLSREADHTLLLHAGPEIAVAST
KAYTAQIAVLSILSQVVAKAHGRDNDIDLLRELAKVTTAIETIVDDTPVM
EQIAKDFLETTRNAFFIGRTMDYNVSLEGSLKLKEISYIQAEGFAGGELK
HGTIALIEDGTPVIALSTQEKVNLSIRGNVKEVVARGAKPCIISMEGLEK
EGDTYVIPHVHELLTPLVSVVTLQLIAYYAALHRGLDVDKPRNLAKSVTV
E
>SH0579 gtaB, UTP-glucose-1-phosphate uridyltransferase
MKQIKKAIIPAAGLGTRFLPATKAMPKEMLPILDKPTIQYIVEEASRAGI
EDIIIVTGKHKRAIEDHFDNQKELEMVLEEKGKDDLLEKVQYSTDLANIF
YVRQKEQKGLGHAIHTARQFIGNEPFAVLLGDDIVESETPAIKQLMNVYE
ETGHSVIGVQEVPESVTHRYGIIDPLEKEGRRYEVKQFVEKPKQGTAPSN
LAIMGRYILTPEIFDYLETQKEGAGNEIQLTDAIERMNSDIPVYAYDFDG
DRYDVGEKLGFVKTTIEYALKDPKMKDELIKFIKELGF
>SH1332 lepA, GTP-binding protein
MDMQERYNRRENIRNFSIIAHIDHGKSTLADRILENTKSVETREMQDQLL
DSMDLERERGITIKLNAVRLKYEANDGQTYTFHLIDTPGHVDFSYEVSRS
LAACEGAILVVDAAQGIEAQTLANVYLALDNDLELLPVVNKIDLPAAEPE
RVKQELEDVIGLNQDDVVLASAKSNIGIEDILEKIVEVVPPPEGDPSEPL
KALIFDSEYDPYRGVISSIRVMEGVVKAGDKIKMMATGKEFEVSEVGINT
PKQLPIEELTVGDVGYIIASIKNVDDSRVGDTITHANRPAEAPLKGYKKM
NPMVYCGLFPIENKDYNDLREALEKLQLNDASLEFEPESSQALGFGFRTG
FLGMLHMEIIQERIEREFGIELIATAPSVIYQCIMKDGSEVTVDNPAQMP
ERDKIDSIYEPYVKATMMVPNDYVGAVMELCQRKRGQFINMDYLDDIRVN
IVYEIPLSEVVFDFFDQLKSNTKGYASFDYEFIENKESNLVKMDILLNGD
KVDALSFIVHKDFAYERGKALVEKLKTLIPRQQFEVPVQAAIGQKIVART
NIKSMGKNVLSKCYGGDISRKRKLLEKQKAGKAKMKAVGSVEIPQDAFLA
VLKMDDE
>SH2128 lgt, prolipoprotein diacylglyceryl transferase
MLFNLNYIDPTAFSIGPLSIKWYGIIIAVGILIGYFIAQESLKYVGLHKD
RLVDVIFYSAIFGFIAARIYFVIFQWPYYAQNPIEIPMIWHGGIAIHGGL
LGGFITGIIVCKIKNLNPFQIGDIVAPSIILAQGIGRWGNFMNHEAHGGP
VSRTFLENLHIPEFIIRNMYIEGVYYHPTFLYESIWDILGFIILITIRKH
LRVGETFTLYLIWYSIGRFFVEGLRTDSLMLTSHIRVAQLVSVILIIIGL
VILIYRRIKYQPSLYKEAGPLTWNSSKAKVKS
>SH2144 llm, lipophilic protein affecting bacterial lysis rate and methicillin resistance level protein
MYTLLLIAVTLVISLILTPMIIKVSIKFDLVDRPNFRKVHTKPVSVLGGT
VILLSFLIGIWLGHPIEREVKPLVMGAIVMYLVGLIDDIYDLKPILKLIG
QIVAASIVAFYGITIDFISFPMGPTIHFGILSIPITIIWIVAITNAINLI
DGLDGLASGVSAIGLITIAFIAILQANVFIIMICSVLIGSLLGFLCFNFH
PAKIFLGDSGALLIGFIIGFLSLLGFKNITFISLFFPIVILAVPFIDTLF
AMIRRMRNGQHIMQADKSHLHHKLLALGYSHRQTVLLIYSIAILFSLSSI
ILYLSQPLGVLLMFILIVITIELIVEFTGLIDDSYRPILNLITKKNEQHH
GDNGVDQHDKK
>SH0610 lrgB, holin-like protein
MVDHLGITTPYFGILVSLIPFVIAQYFYKKTNGFFLLAPLFVAMVAGIVF
LKVTGISYENYKIGGDIINFFLEPATISFAIPLYKKRDVLKKYWLQIFGG
IAIGTLIALILIYLVAIVFQLGDQIGASMLPQAATTAIALPVSQGIGGVK
ELTSLAVILNAVVISALGTKIVKWFKISNPIARGLALGTSGHTLGVAAAK
ELGETEESMGSIAVVIVGVIIVAIVPPLASILF
>SH1718 lsp, Lipoprotein signal peptidase (Prolipoprotein signal peptidase)
MKKKYYITISLIVAIAILIIDQVTKRIIATTMNIGDSYEVIPNFLNITSH
RNNGAAWGILSGKMGFFYIITIVILIVLVLFYIKEAKYNLFMQVAISLLF
AGALGNFIDRLVNGEVVDFVDTNIFGYDFPIFNVADSSLTIGVLFIIIAL
LKDANSKE
>SH1289 lytH, N-acetylmuramoyl-L-alanine amidase
MNHSDQGSNRITVSENAELRTGPNAAYPVIYQVEKGDTFTRLSKSGKWIE
VESRDGSEKSWIAGWHTSLNIEAGANKKVNPLKNKVIVLDPGHGGNDQGA
SSNTSKKSLEKNYTLKTAKELRRALEKAGATVKLTRSDDTYVSLDDRKLN
GDAYISIHNDSLDSPNANGATVYWYKNNQEALAETLNTNIQKKAMLFNRG
TRQENFQVLRQTNKPAVLLELGYISNPTDEVMIRNQIHRQVVEEAVVDGL
KQYFAS
>SH0091 mecA, penicillin binding protein 2 prime
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSS
YISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYK
IKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSE
RGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQ
MDQNWVQDDTFVPLKTVKKMDEYLRDFAKKFHLTTNETESRNYPLGKATS
HLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAI
HPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTS
PGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVN
GNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYN
AQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLL
KDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISG
KVYDELYENGNKKYDIDE
>SH1133 menC, O-succinylbenzoic acid (OSB) synthetase
MLIKAVNLYLYNQEFVNPIVTPKVKMTHRKALIVEILSEDDQSFFGECNA
FETNWYNEETIETVQEILSQWSESIVKNSFHKYEDWKPYLDILDNYPAAR
STLVMAIYQMYHDLPKFKVAYGATISGISAQQLEYLKQTQPKRIKLKWTG
QLNDDISLLDDILPYDFELALDANESLDVSDFQKLESINDQNILYVEEPF
KSLSSILHIDHTQYPAIALDEKATDINSIISIVNQFPVKVVVVKPFRVGG
LDRVQSLIRELKSIDIKVVIGGMYEYGLSRYFTALLAREGDYPGDVTPDG
YYFTDDFTQGVGKLKEGMISFHPPQIDKSKLLKLY
>SH0924 mnaA, UDP-GlcNAc 2-epimerase
MKKIMTVFGTRPEAIKMAPLVKALEYDAELEPMIVVTAQHREMLDSVLHT
FNIKPHYDLNIMEEGQTLSDITSRAMTKLEDVIKKERPDMVLVHGDTTTT
FSGALAAFYNKVAIGHVEAGLRTRHKYAPFPEEVNRQMVSNLADLHFAPT
KGAANNLLQENKSPDSIIITGNTAIDTLELTIQKEYTSDIIRKHQGKRII
LLTVHRRENVGQPMINIYKAMRKIVDEYEDIVIVSPLHLNPKVRELAYEY
LGEHERIELIEPLDVVDFHNFANKAYLILTDSGGIQEEAPSLNKPVLVLR
DVTERPEGVTAGTLKVVGTDFDNVFKSTTEILENQMIYDQMALTQNPYGD
GNASLRICESIKYYFGLTSKMPKPFNS
>SH1733 mraY, phospho-N-muramic acid-pentapeptide translocase
MLFILAVIALLITFILVPILIPTLKRMKFGQSIREEGPQSHMKKTGTPTM
GGLTFLISIIITSIIAIFFVDNSNPIILLLFVTIGFGLIGFIDDYIIVVK
KNNQGLTSKQKFLAQIAIAVVFFLLSDVFHLVEFSTNLNIPFTNISIPLS
FAYVIFIVFWQVGFSNAVNLTDGLDGLATGLSIIGFTMYAIMSFVLDSPA
IGAFCIIMIFALLGFLPYNLNPAKVFMGDTGSLALGGIFATISIMLNQEL
SLLLIGLVFVIETASVMLQVASYKLTKKRIFKMSPIHHHFELSGWGEWKV
VTVFWTAGLISGLIGLWIGVH
>SH1560 mscL, large-conductance mechanosensitive channel
MLKEFKEFALKGNVLDLAIAVVMGAAFNKIVTSLVTYIIMPLIGKIFGSV
DFAKDWEFWGIKYGLFIQSIIDFIIVAIALFIFVKIANTLVKKEEPEEEI
EENTVLLTEIRDLLRAK
>SH0935 murA, UDP-N-acetylglucosamine 1-carboxyvinyl transferase 1
MDKIVIKGGNRLTGEVKVEGAKNAVLPVLTASLLASEGQSKLVNVPDLSD
VVTINNVLSTLNANVEYNKEEGAVLVDASTTLKEEAPYEYVSKMRASILV
MGPLLARLGHAIVALPGGCAIGARPIEQHIKGFEALGAEIHLENGNIYAS
TKDGLKGTDIHLDFPSVGATQNIIMAASLAKGKTVIENVAKEPEIVDLAN
YINEMGGKVTGAGTDTITIHGVEKLRGVEHSIIPDRIEAGTLIIAAAITR
GDVFVRDAVKEHMTSLIYKLEEMGVNLDFQEDGVRVTAEDELKPVDVKTL
PHPGFPTDMQSQMIALLLTAEGHKVITETVFENRFMHVAEFRRMNANITV
EGRSAKIQGKSQLQGAQVKATDLRAAAALILAGLVAEGTTQVTELKHLDR
GYVNFHEKLKSLGANIERVNY
>SH2153 murB, UDP-N-acetylmuramate dehydrogenase
MLKQEDILQDLKSLIPEDIIKVNEPLKRYTYTETGGNADFYLSPTKNEDV
QAIVRYAKEKDIPVTYLGNGSNIIIREGGIRGIVISLLSLNHINVSDDAI
IAGSGSAIIDVSRAARDHVLTGLEFACGIPGSVGGAVYMNAGAYGGEIKD
CIDYALCVNEEGDLIQFTNKELELDYRNSIVQKQHLVVLEAAFTLEPGKL
DEIQAKMDDLTERRESKQPLEYPSCGSVFQRPPGHFAGKLIQDSDLQGYR
VGGVEVSKKHAGFMVNVDNGTATDYEDLIHHVQKVVKEKFDVELHREVRI
IGEHPKE
>SH1182 murC, UDP-N-Aacerylmuramate-alanine ligase
MTHYHFVGIKGAGMSSLAQIMHDLGHEVQGSDIEKYVFTEVALKNKGIKI
LPFNADNIKEGMVVIQGNAFPDTHEEIVKAHDLKLDVIRYHDFLGHVIDQ
YTSVAVTGAHGKTSTTGLLSHVMNGDKKTSFLIGDGTGMGLPASDYFAFE
ACEYRRHFLSYHPDYAIMTNIDFDHPDYFKDIDDVASAFQSMAHNVKKAI
IAWGDDDHLRQLKADVPIYYYGLNKNDDIYADNIQITDKGTQFDVYVNGE
YYDQFLSPQYGDHNIQNALAVIAISYLEKMDVNNIKEALETFGGVKRRFN
ETNVANQVLVDDYAHHPREISATIETARKKYPNKDIVAVFQPHTFSRTQA
FLDEFATSLSKADHVYLCEIFGSIRENTGDLTIQDLINRIDGSALIEENN
IDVLDQFDNAVILFMGAGDIQKLQRAYEEHVGMTNEF
>SH1732 murD, UDP-N-acetylmuramoylalanine-D-glutamate ligase
MLNYTGLENKDVLVVGLAKSGYEAAKLLIKLGANVTVNDGKDLSQDPHAK
DLEALGVKIVDGGHPLSLLDNEPIIVKNPGIPYTVSIIQEAYQRHLKILT
EVELSYLISEAPIIAITGTNGKTTTSSLIGDMFKKSRLTGRLSGNIGYVA
SKVAQETSPNEYLITELSSFQLLGVEQYRPHIAIITNIYSAHLDYHETLE
NYQNAKKQIYKNQTENDYLICNYHQRHLIESENLKAKTLYFSTQQEVDGI
YIKDGFIVYQGIRIINIDDLVLPGEHNLENILAAVLASILAGVPIKAIID
SLTTFSGIDHRLQYIGTNRTNKYYNDSKATNTLATQFALNSFKQPIVWLC
GGLDRGNDFDELIPYMKNVRVMVVFGQTQEKFAKLGNSQGKLVVKATDIE
DAVKKVQDVVEPNDVVLLSPACASWDQYKTFEERGERFIESFRAHLPSY
>SH1941 murE, UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase
MNANELFEKIRVKQVIGTLDINVTDITTDSRTASEGSIFVASKGYTVDSH
KFCQNVVDQGAKVIVVNHQQDINGDVTQVIVPDTLRVASLLAHTLYDFPS
HQLTTIGVTGTNGKTSIATMIHLIYRGLGKGSAYLGTNGFQINEHKTRGA
NTTPETVSLTKKIKQAVDENAEAMTMEVSSHGLSLGRLRGVEFDVAIFSN
LTQDHLDFHGTMEAYGHAKSLLFSQLGEDLSKEKYAVLNNDDDFSKYLAS
VTPYEIFTYGIDHDAQFMAKNIQESLQGVHFDFDTPIGTYSVKTPYVGKF
NISNIMAAMIAVWSKGTSMEDIVRVVENLEPVEGRLEVLDPSLPIDLIID
YAHTADGMNKLIDAVKPFVKQKLIFLIGMAGERDLTKTPEMGAVACRADY
VIFTPDNPANDDPKMLTAELAKGATHNHYVEFDDRAEGIKHAIDIAEPGD
TVVLASKGREPYQIMPGHIKVPHRDDLIGLEAAYKKFGGGPSEH
>SH0955 murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate-D-alanyl-D-alanyl ligase
MIEVTLQQIQEWIPCDIDSQYLRQTIKGVTIDSRAIKTNMLFIPFKGENV
DGHCFVSQALKDGAGASFYEKGHDIDDNVKGPIIWVDDTLIALQQLAKAY
LKHVNPKVIGVTGSNGKTTTKDMIESVLHTEFKVKKTQGNYNNEIGLPLT
ILELDLDTEISILEMGMSGFHEIELLSNIAEPDIAVITNIGESHMQDLGS
REGIAKAKSEITIGLKKEGTFIYDGDEPLLEPHVKKIKHAKCLSVGLKQD
NALVCEVEHSENDGIAFSINGNEHYKLPILGIHNMKNAAIAIAIGHELGL
KYETIQHNINHVQLTGMRMERHITDDDITIINDAYNASPTSMKAAIDTLS
QMEGRKIIVLADSLELGENSRSMHEEVGAYLEGKNIHTLLTYGKDAKYIS
DIGGQFVDHVEYFIDKQQLTQYLINNLVANDKVLVKGSRGNKLEEVVNKL
I
>SH1488 murG, undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase
MSKIAFTGGGTVGHVSVNLSLIPTATDKGHDAFYIGSKTGIEREMIESQL
PNIEYYPISSGKLRRYLSVDNAKDVFKVLKGVIDARKVLKREKPDLLFSK
GGFVSVPVVIAARSLNIPTIIHESDLTPGLANKISLKFAKKIYTTFEDTL
KYLPKDKADFVGATIRQDLKEGNQSRGYQLTGFDASKKVLLVMGGSLGSK
KLNQAIRENLEALLQDYQIIHLTGHGLVDSSIDAKGYVQYEFVKEELTDL
LAITDTVVSRAGSNAIYEFLTLRIPMLLIPLGLDQSRGDQIDNAENFESK
GYGRTIPEDQLTQVKLLEQLKEIENDRESIIKQMETYRESYTKEDLFNKI
LKDAL
>SH1811 murI, Glutamate racemase
MNKPIGVIDSGVGGLTVAKEIMRQLPNETIYYLGDIARCPYGPRPGDEVK
QFTTQLANKLMQFDIKMLVIACNTATAVALEHLQQMLPIPVIGVIEPGSR
TAIMTTKNQNVLILGTEGTIKSEAYRHHIKHINPNVHVYGVACPGFVPLV
EQMRYDDPTITSIVIHQTLKQWRNTDADTIILGCTHYPLLYKPINDYFGG
EKKVISSGLETAREVSALLTFSNEHASYTQHPEHRFFATGDTVHIKNIIL
QWLKLDVEVERISVDE
>SH0911 murZ, UDP-N-acetylglucosamine 1-carboxylvinyl transferase 2
MTQEVIKIRGGQTLKGDVTISGAKNSAVAIIPATLLAQGQVKLDGLPQIS
DVETLVSLLEDLNIKAHLNGKTLEVDTSEIENAPLPNNKVESLRASYYMM
GAMLGRFKKCVIGLPGGCPLGPRPIDQHIKGFKALGAEIDESNDTSMKIE
AKELHGANIFLDMVSVGATINIMLAAVHATGQTVIENAAKEPEVVDVANF
LNSLGADIKGAGTSTLKINGVDSLHGSEYQIIPDRIEAGTYMCIAAAVGE
EITINNIVPKHVEALTVKLKELGVDIQVDGDAEKAIIKRKSSYKNVDIKT
LVYPGFATDLQQPITPLLFMADGPSFVTETIYPARFRHVDELKNMGANIE
ADMETGTATIKPSSLNGAEVYASDLRAGACLIIAGLLAEGVTTIYNVRHI
YRGYTDIVKHLKELGANIWTEEV
>SH0282 nanA, N-acetylneuraminate lyase subunit
MEDKLKGLYAALLVPFDEHGQVKEEGLKQIAKNAIETEKLDGLYVNGSSG
ENFLISKEQKKQIFRVVKETVGDDVNLIAQIGSLDLNEAIELGKYATELG
YDALSAVTPFYYPFSFEEIKQYYFDIIEATQNNMIIYAIPDLTGVNISIE
QFGELFNHEKVVGVKYTAPNFFLLERIRKAFPNKLILSGFDEMLVQATIS
GVDGAIGSTYNVNGRRARQIFDLAREGKIAEAYQIQHDTNDIIETVLSMG
IYPTLKEILKSRGIDGGLPKRPFRPFDESHRDALDTLIKKYDL
>SH2171 opuBC, 
MSELFSTLNDRKGEVLTTILEHIQISFIALLIAILIAVPLGIALTKTKRL
SEVVMNIAAILQTIPSLALLGLMIPIFGIGRVPAIIALVVYALLPILRNT
YTGIKEVDPSLIEAAKGIGMKPMRRLTKVELPIAMPVMMAGIRTAMVLII
GTATLAALIGAGGLGDLILLGIDRNNTSLILIGAIPAALLAIMFDLILRY
MEKLSYKKLLITVGAMILIILLVIVVPLFGKKGDTITLAGKLGSEPSIIT
NMYKILIEDETDDTVDVKDGMGKTSFLFNALKSDDIDGYLEFTGTVLGEL
TKEDLKSKKEDAVYQQAKQSLEKKYDMTMLKPMKYNNTYALAVKRDFAKE
NNIKTIGDLQKVEDKIKPGFTMEFNDRSDGYKAVAKAYGLNLSNVKKMEP
KLRYTAVEKGDINLIDAYSTDAELKQYNMVVLKDDKHVFPPYQGAPMFKE
KFLKQHPEIKKPLNKLEGKISDEEMQEMNYKVTVKNEDPYNVAKHYLEKE
GLVK
>SH0608 opuCC, glycine betaine/carnitine/choline ABC transporter opuCC
MKKLKLTFILLAMSLIVLSGCSLPGLGDGDGKDSVKITATETSETKIMAN
IEKLMIEHYTNGKIKPTIVGNLGSSIIQHNALQRGDVNMSAVRYTGTELT
SVLDAPPTKDTKKAMSESQRLFKEKYNQKYYDSFGFENTYAFMVTKEVAE
KYHLEKVSDLKKYKDELRLGMDTQWMNRAGDGYPAFQKEYGFKFASARPM
QIGLVYDALKNKKLDVAVGYSTDGRIAAYDLKILKDDRKFFPPYDGSPLA
TEKLIKDHPEIDKALKKLQGQISTKEMQKLNYEADGKGKEPAVIAEEYLK
KHNYFEDDSKKGGQK
>SH0853 opuD, 
MRKKSISFVFWIALAICTLFVLYGAFMPKQLETGTQNITSFIAKNFSWYY
LLLVLLIFFVCVYLLFSRYASITLGEEGEDPEFSLPSWFAMLFSAGMGIG
LVFWTTAEPISHAFTLTPIHKAGTQSAINDAFQFSFFHWGLHAWAVYGIV
ALVFAYFSFHKGYPGLVSATLVPIFGEKSMKGPIGGAIDVLAVIATVTGV
AATLGFGALQINEGLNFLFNVPNNFGTQVILIIIATILFTWSAWSGIDKG
IKTLSNVNMFLAFIVLIGLFIVGPTLYILNTFTNGLGNYIFNFFSMSLRI
PMNGGEKFQWLQNWTIFYWAWWVSWAPFVGIFIARVSRGRTIKEFILGVL
FVPALVCFFFFAVFGASAVYLQDKGIANIAKEATETATFATLEHYPLGFI
LSIITLVVIMIFFVTSADSATYVLGMLSSKGDINPASFVKVSWGIILALF
AMIMIYTGGTQAIQNLLIIAALPFSIVIILMIWSLFKSLSIDHPRTSNKF
PNILQYKSSKQKELKK
>SH1559 opuD, glycine betaine transporter
MNSSSEETKQNKKFSSVFIYSAIVVAIVVSIGAFLPEQFGKITGDISSWI
TEKLGWYYMILTTVIVFFCIFLIFSPIGKLKLGKPNDKPEFNTVSWFAML
FSAGMGIGLVFYGAAEPMADFASPPNADPKTTEAYTEALRSTFFHWGFHA
WAVYGVVALALAYAQFRKNEPGLISRTLRPILGDKVEGPIGTIIDVLSVF
ATVVGVAVSLGMGALQINGGLHYLFGVPNNVWVQSIIIVVVTILFLASAW
SGLSKGIQYLSNLNIGLGTVLMIIALIIGPTVLILNMFTSSTGSLLNSFL
FNSFDTAALNGQKREWMSSWTLYYWGWWLSWSPFVGVFIARVSKGRSIRE
FISGVLLVPAIVSFLWFSVFGVLGIETGKKHPELFKMTPETQLFGVFHHV
PLGMALSLIALVLIASFFITSADSATFVLGMQTTFGSLEPSSAVKVTWGV
SQSLIAFILLLAGGGNGADALNAIQSAAIISAFPFSFVVIMMMISFYKDA
NQERKFLGLTLQPNKHRLQDYVKYQQQDYESDILEKRESRRNAEK
>SH1462 pbp2, penicillin-binding protein 2
MTENKGSSQPKNGKNGKSKAKKNKNVKRTIIKIIGFLLIAFIVLVLLGIL
LFAYYAWKAPAFTESKLQDPKPAEIYDRNGDLVKKLDNGARREHVELKDV
PKNMRNAVLATEDNRFYDHGAIDYKRLFGAIGKNLTGGFGSQGASTLTQQ
VVKRAFLSEEKSIGRKAQEAYLSYRLEQEYSKDEIFQMYLNKIYYSDGVY
GVKAAAKYYFNKDLKDLNLAEEAYLAGLPQVPNLYNIYDNPKQAENRKNT
VLYLMHYHNRISDKEYNAAKKINLKANLVDRTAKERQIGTDNSDSEYDSY
VNFVKSELMNNKEFKNKNLSDVLQSGIKIYTNMDKDVQKTLQDRIDNGNY
YKNEDQRVGSTILDSKTGGLVAISGGRNFKDVVDNNAATDAHLTGSSLKP
FLAYGPAIENMQWATNRAIQDESSYSIDGGTFRNYDGNGHGTVTAYDALR
QSFNIPALKTWQQVNSQAGDNAVKKFASKVGLDYQSDIGPSDVLGGGASE
FSPTQLASAFAAIANGGTYNNAHSIQKVVTADDDTIEFDHTSHKAMKDYT
SYMLAEMLTGTFKAYGSAYGHGVSGVTMGAKTGTSTYGTEINQQYNLPDN
AAKDVWINGFTPKYTMSIWMGFSEIKEGGVNSFLGHSEQEYPQYLYEDVM
SDITSSDDGDFKKPDSVNGSSADNLSVSGHPDNNTTNREVNGSSGSSSSN
SSNSSNNSSNSNTSNTNNSGNTNSGTTNNNSTTQGTNTVGSTLSNIFNLN
SIFDFKKSS
>SH1364 pbp3, penicillin-binding protein 3
MLKRLKEKSNDEKIKHTMNKRISFVFGAIVVIFGIIVLRLGYLQIAQGSQ
YSQLVKNDENITVNESVPRGRILDRNGKVLVDNASKLTITYTRSRKTSQK
DMLDTAKKLSSLITMKTDKITERDKQDFWIQKHQDEVDKLMKKETSMLNE
GSITQDQYDKQLYKKVGDKQINSLSKKDLRVLAIYREMSAGSTMNPQTIK
NEDVSEKEYAAVSQQLDSLPGVNTTMDWDRRYPYGDTLRSIFGSVSTSSE
GIPKELTEQYLAKGYSRNDRVGKSYLEYQYEDILRGKKKEMKYTTDKSGK
VINSEVINPGSRGDDLQLTIDIDLQKKVESLLENQIKTLRSQGAKDMDNA
LIVVQNPKNGDILAMAGKQIDKNGKLTDYDLGNFTGQFAVGSSVKGGTLL
AGYQNNAIKVGEEMIDEPLHFKGGLTKRSYFNKNDKVRINDKEALMHSSN
VYMFKTALKLAGDPYYSGMGLPTDISEAGQKLRKGLNQVGLGVKTGIDLP
NETIGQIEPLTNNSGNYLDLSIGQYDTYSPIQLSQYVSTIANDGYRIQPH
IGLAIHDATNSDDIGPVKQKIKGNVLNKVNNSEDEIKEVQKGFEMAFNEK
DGTGYSSFHKTKVPSAGKTGTAEVFQDGESRVNSTYIGYAPINNPKLSFS
IVYTNQPVPPPWLNGGDLGRDVINYYFDDKK
>SH2254 pbp4, penicillin binding protein 4
MKRSLIITFALLLTIVIIAPNSYASEYEPTPTEIARQYGYPNVTDAYQPE
GSINVSQTGQILYDYQSNQKWYPASMTKLMTMYLTLEAVNKGELSLNDKV
HITDKHYRMSTLPELSNTKLYAGETYTISELLQITVSNSSNAAALILADE
VSGNVNDFTDLMNKKAKALGMSNTHFVNPTGAENKQLKEFAPSKYKNQDN
TTSTAKDFAILDHHVIKETPKILHFTKQLAPTQHGVTYYTFNHSLEGAKM
SLLGTDGLKTGSSDVADYNHTITTKRNNFRINQVIMGAGDYVNLGGEKQR
NMMGNAMMNRSFDQYSYKKVLSKGTHKINGKKYYVKDNLYDVVPKGMNKK
DYKFIVKDGSIHLDYNRQFLTKDDGPPKVEVTKPLLHKANTIAQTTWKEH
PVVTFVALALLAIAFILMVRSIIHLLFKRK
>SH1734 pbpA, penicillin-binding protein 1
MAKRKIKIRKNKLGAVLLVGIFRLLFFILVLRYSYIMITGHSDGQDLVMR
ANEKYLVQNNEQAERGKIYDRNGKILAEDVERYKVVAVVDKSAGKSGDKP
RYVEDKKKTAKELSKIIDMKPEEIEKQLNQKKAFQVEFGQKGTNLTYQDK
QKLEKMDLPGITLYPETERFYPNGNFASHLIGMAQKNPDTGELKGALGVE
KIFDSYLSGTKGALSYIQDIWGYIAPNTKNEKSPKRGDDVHLTIDSNIQV
FVEEALDDMVKRYQPKDLFAVVMDAKTGEILAFSQRPTFNPETGEDFGKK
WANDLYQNTYEPGSTFKSFGLAAAIQEGKFNPKKKCESGHRDIMGSRISD
WNKTGWGEIPMSLGFTYSSNTLMMHLQDLVGADKMKSWYERFGFSKPTGG
LFDGEAEGNIAWSNELQQKTSAFGQSTTVTPVQMIQAQSAFFNKGNMLKP
WFVDSIKNPISKKTFYQGEKEIAGKPITASTASKVETELDKVVNSKKSHA
MNYRVDGYDIEGKTGTAQVADEKSGGYVKGENPYFVSFIGDAPKKNPKVI
VYAGMSLAQKNDQEAYEMGVSKAFKPIMENTLKYLNVGSKKDETKSAQYS
KVPNVTGQSTDKAKESLKSEDLQATVIGNGDNVKSQSIKANKKLLPNSKV
LLLTDGDITMPNMKGWTKDDVLAFQELTGINVTTKGSGYVTKQSVNNGTT
LKDNSKVEIELSPEDPDDTSTNTNDNETASNDSSNKDKASSSSDDKEKDN
KNDTSSSSEQEQQTNNSQDSNE
>SH0533 pgsA, poly-gamma-glutamate synthesis protein PgsA
MKKKKRLSASEWLLKQSKRHKRFNFSYTLIVLIVALVLLVFAIRAVKVEP
VEAMPSSGNDYIRSTYLGNITLNKHFRQMDLNDVFKGLKQPLQQSDFSTA
SLLVSHFSNDPKTNIKKNIENIMFLKKENVKSVNLINNTIDNVQAQDLSK
QVEAQTDYNFMTGNGSNPINSKTVQQTVKGKKIANVSFTDVGSNYEDPLK
NTTSISLDPKIFVPLIKNLKENNDLVVVNVDWGITNERSVTDRQKEYAHA
LVKSGADVIIGHNSVVQKVEKYKNASIFYSLGILTSDSFLSKNQKGMVVQ
HDWNGQHNKFSITPVRGADGKITKDNMNKMEAQRYYNNINDKSIHLKEEN
GGYTFEY
>SH1191 sgtA, 
MLTNINRDTKFNSFEKFYKKTKHAIVGLFSVGLFICLIGFIGTVIYFNHL
THESSKISDRELKQKVLHFAGDDLINHENSDVLSEYDKSENSLIVGPKHV
NPNVIKALTSSEDTMFYKHKGILPKALVRAMIQDVFNLDQSTGGSTITQQ
LVKNQVLSSKKTYSRKANELILAMRLENLLSKNEIIYTYLNIVPFGRDYE
GNNITGIASASYSLFGIPPKDLNIAQSAYLIGLLQSPYMYTPYEENGELK
TYKEVKISVDRQHYVLKRMLVEGVIDKEEYRHAKRYHIYDHLLTKPQLNN
NQSA
>SH1086 sgtB, monofunctional glycosyltransferase
MKRSQRMNNSPERHSQYRNEPHYNTYYQPVGKPPKKKKNKRIFLRLFIIF
VFIYALFIGLMYYLSSRANVDDLKTIENKSSYVSADNMPDYVKGAFISME
DERFYKHHGFDVKGTTRALFSTIGDRDVQGGSTITQQTVKNYYYDNERSF
TRKLKELFVAHKVEQQYSKNEILSFYLNNIYYGSDQYTIESAANYYFGTT
VNKNSDSMSQITVLQSAILASKVNAPSVYDISNMSDNFKNRIKTNLEKMK
QQEYISDSQYQEALSQLNNY
>SH2513 spoVG, 
MKVTDVRLRKIQTDGRMKALVSITLDEAFVIHDLRVIEGNSGLFVAMPSK
RTPDGEFRDIAHPINSDMRQEIQDAVMKVYDETDEVIPDKNASSEDSDEA
>SH0543 srtA, sortase A
MKNWINRLMTILGVILILVAVYLFAKPHIDNYLHEKDNDNKIEQYDKQDK
SSNKQTPTIPKDKTKMAGYISVPDAEIKEPVYPGPATPEQLNRGVSFAEK
DESLSDQNISIAGHTFTDRPHYQFTNLKAAKKGSKVYFKIGNETREYKMT
SIRDVNPDEVEVLDEHKGEKNQLTLITCDDYNEQTGVWEKRKIFVAKQVN
>SH2260 tagA, teichoic acid biosynthesis protein
MHDQKETTATKVDILGVQFNNVTMLDMIEHVKTFFTQETEDNLFIVTANP
EIVDYASEHSTYKQLINSADFVVPDGTGVIKASNRLGTPLKRRVPGIELM
EHCLKIAHTNYQKVYLLGAKNEVVTLAHKNLQHKYPQAQFDYHHGYIDLN
DETVIKRIKRFDPDYIFVGMGFPKQEEWIQKHRHTFKRTVMMGVGGSFEI
YSGTKKRAPKLFIKLNIEWVYRLLIDWKRIGRMRSIPKFMFKVFKVQRKM
KKKK
>SH2257 tagB, teichoic acid biosynthesis protein B
MRLIIKKVYMLMITLLNFIYKRRQVDKKQITVLMTFPEDVMPIINELDNK
GYKITVIAKFEEQYRLEHLNNITFIPAGNKYIVKHIKALSSSKVILIDTY
YLMLGGYTKKKAQTIIQTWHASGALKNFGLTDHQVDLNNVTMVRQYQRVY
QATDYYIIGGKEMGTCFKESFEATEDQLLPLGLPRLSQYLKFNLKAEQER
LKKHYNIHKKLVVYVPTYREGSENNRQIDVARFEEALPEYTLINQLHPSI
SKSQSIATTQELMIMADVIISDYSSLPIEASLLDKPTLFYVYDEHKYDKI
RGLNQFYKAIPQQYKVTTEEELILKIRNDIALFKPLFKNWHKYNREDSVR
RVTEFIEKMVKR
>SH2255 tagD, teichoic acid biosynthesis protein D
MRRVITYGTYDLLHYGHIELLRRAREMGDYLIVALSSDEFNQIKNKKSYY
DYEQRKMMLESIRYVDLVIPENDWGQKEIDVDRFEVDVFVMGHDWEGEFD
FLKDKCEVVYLKRTEGISTTKIKQELYGKDAK
>SH2250 tagF, glycosyl/glycerophosphate transferases involved in teichoic acid biosynthesis TagF
MNKLSIIITYFNNEDYISECIHSLKSQRNQDFDIIVVDDGSTDRSTEILQ
EALKSYDKDVHFIQLQENTGHAHARNVALEQAHGQYVLFLDADDQLASYA
VDYYLQHVNGLDTLIAPIHKFRSQRPQYVDKDKVRLQYASHQKSPNAILR
KESACNILFKNAIIKAHQIQFNESLDIYADTSFVLEYLKYAERFVRITNF
PFYYRGEVYDPFYGNTLSDQDFTNKFEDHVNSFFDAMQRTNDKRIKNFLI
QRMKNEIKSGFDPALRDIKSRYVSLEDALIKIVKALKWNILKDGKVLYNL
EILFLSMDDVENAKYVNDLRNKTRLVKNIVLNSKMKERSKYQLSDNEDLV
DPNTIVFEAFGGKNYSDSPKYIYEYMQKHYPHLNYIWVFSKPENNNIPGN
ATKVKKGSQAYYDAYAKAKYWVTNARLPLYLNKKENQMYIQTWHGTPLKR
LANDMKVVRMPGTTTANYKKNFYAEASRWDRLVSPNRYSSDIFKSAFWMD
EDRIWEIGYPRNDVLVNRQNDTEYIEQIKRDLNLPADKKVIMYAPTWRDD
EFVKKGQYLFDLKINLANLQKEIGDEYVILLRMHYLIANALDLHGYDDFA
IDVSNYNDISELYLISDALVTDYSSVMFDFGILKRPQFFFAYDIEKYDKG
LRGFYMDYMNDLPGEIITDEFKLAEELKQIDQHKVKYQDKIESFYNDFCS
IENGKASQYIGDYIYKDIEKKS
>SH2258 tagG, teichoic acid translocation permease protein
MKAWLISMSAVGSVFKEHIKNFYLVQRLAQFQIKITNTNNYLGVAWELLN
PALQIMVYWFVFGMGIRSNQPIHGIPFIYWLLVGISMWFFVNQGILEGTK
SVSMKFNQVAKMNFPLSIIPTYTVTSRFYGHIGLLLIIIGICIVNGIFPS
IHIVQLLIYVPMTFFFTASVALFTSTLGIIVRDTQMIMQALLRILFYMSP
ILWVPKDSGIGGTIGEIIKFNPVYFLAESYRAAILFHEWYFIEHWKLLLY
NVIVILIFFVLGSILHRRYRDHFADFL
>SH2259 tagH, teichoic acid translocation ATP-binding protein
MSVSVNINNVTKEYRIYRNNKERIKDALIPKNKNNTFFALDDVSITAHEG
DVIGLVGINGSGKSTLSNMIGGSISPTSGNIERNGEVSVIAINAGLNGRL
TGVENIEFKMLCMGFKRKEIKQLMPQVIEFSELGEFIHQPVKNYSSGMRA
KLGFSINVTINPDILVIDEALSVGDQTFTQKCLDKIYEFKEANKTIFFVS
HNIRQVREFCTKIAWIEGGKLKEYGDLEEVLPKYEQFLKDFKKKSKADQK
AFRKGLDEKRFIVK
>SH2256 tagX, teichoic acid biosynthesis protein X
MKIAIIIPVYNAEKTIRRAIKSIDTTHEVEIICVNDGSTDHSRHELTQLQ
KEVKNIMIYNQDNQGAAASRNFGLAAMSDDVEAFMFLDADDQFLPGRLDK
MIDYYERNQEVDIVIGQIGRGVQGDWKIIPTHEEINRESLVSLAEAPEIL
QSIGPGGKLFNSKFSALRFDEDVVFCEEHTFVTRAYLTARDIQLLPLIIY
GYNEQEGSITDKRADTFISYIEDARRVRQRVMEMLLLTNEKAYYSYRMDD
LIVSYLIQAYLLKCSKVTPEFIDKVTHYIKDMQHTNYSGDALFRIIQAVE
QGATNWTRDTYEKWRQTLIDVGIGRPGYFRFQAQVMPKKFAFSSKQLVKR
TLKR